Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:Drug-Related Side Effects and Adverse Reactions
go back to main search page
Accession:DOID:9006810 term browser browse the term
Definition:Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Synonyms:exact_synonym: Adverse Drug Reaction;   Adverse Drug Reactions;   Drug Side Effect;   Drug Side Effects;   Drug Toxicities;   adverse drug event;   adverse drug events;   drug toxicity;   side effects of drugs
 narrow_synonym: antidepressant-induced dizziness
 related_synonym: Brain pseudoatrophy, reversible, valproate-induced, susceptibility to
 primary_id: MESH:D064420
 xref: EFO:0006321;   EFO:0020003



show annotations for term's descendants           Sort by:
Drug-Related Side Effects and Adverse Reactions term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18381794 PMID:20563569 PMID:21064136 PMID:24502637 PMID:25007187 More... NCBI chr 9:93,049,955...93,146,469 JBrowse link
G ABCC1 ATP binding cassette subfamily C member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18256692 NCBI chr 3:28,360,868...28,472,940
Ensembl chr 3:28,360,873...28,473,456
JBrowse link
G ABCC12 ATP binding cassette subfamily C member 12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr 6:36,559,645...36,653,044
Ensembl chr 6:36,557,290...36,649,715
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20216337 PMID:23222202 PMID:25007187 PMID:32387182 NCBI chr14:110,955,698...111,038,898
Ensembl chr14:110,955,633...111,037,537
JBrowse link
G ABCC4 ATP binding cassette subfamily C member 4 (PEL blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:23222202 NCBI chr11:64,089,149...64,309,831 JBrowse link
G ABCG2A ATP binding cassette subfamily G member 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 PMID:32387182 NCBI chr 8:130,853,414...130,945,388
Ensembl chr 8:130,889,684...130,945,393
JBrowse link
G ACHE acetylcholinesterase ISO CTD Direct Evidence: therapeutic CTD PMID:27083141 NCBI chr 3:8,732,451...8,738,274
Ensembl chr 3:8,732,441...8,738,605
JBrowse link
G ADORA1 adenosine A1 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:15641640 NCBI chr 9:113,835,279...113,875,899
Ensembl chr 9:113,835,921...113,872,365
JBrowse link
G ADORA2A adenosine A2a receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:15641640 NCBI chr14:49,467,186...49,485,845
Ensembl chr14:49,468,877...49,485,850
JBrowse link
G AFM afamin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 8:69,706,823...69,728,269
Ensembl chr 8:69,706,896...69,728,255
JBrowse link
G AHSG alpha 2-HS glycoprotein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr13:124,426,313...124,438,848
Ensembl chr13:124,426,308...124,438,840
JBrowse link
G ALB albumin ISO CTD Direct Evidence: marker/mechanism CTD PMID:24361871 PMID:28885000 NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
JBrowse link
G AMBP alpha-1-microglobulin/bikunin precursor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 1:254,683,885...254,703,220
Ensembl chr 1:254,683,891...254,703,225
JBrowse link
G APOB apolipoprotein B ISO CTD Direct Evidence: marker/mechanism CTD PMID:31186542 NCBI chr 3:117,250,096...117,316,200
Ensembl chr 3:117,250,096...117,316,200
JBrowse link
G ARID5B AT-rich interaction domain 5B ISO CTD Direct Evidence: marker/mechanism CTD PMID:24712521 NCBI chr14:65,408,603...65,598,485
Ensembl chr14:65,408,598...65,598,485
JBrowse link
G ASS1 argininosuccinate synthase 1 ISO protein:increased expression:plasma (rat) RGD PMID:20544730 RGD:4140449 NCBI chr 1:270,531,434...270,586,364
Ensembl chr 1:270,531,589...270,586,364
JBrowse link
G ATIC 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16947783 NCBI chr15:117,617,584...117,649,063
Ensembl chr15:117,617,502...117,649,107
JBrowse link
G B2M beta-2-microglobulin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 1:126,837,721...126,844,043
Ensembl chr 1:126,835,143...126,981,582
JBrowse link
G BCHE butyrylcholinesterase ISO CTD Direct Evidence: marker/mechanism CTD PMID:3111302 NCBI chr13:104,946,732...105,007,568 JBrowse link
G C3 complement C3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
JBrowse link
G CACNA1H calcium voltage-gated channel subunit alpha1 H ISO CTD Direct Evidence: marker/mechanism CTD PMID:30552955 NCBI chr 3:40,637,420...40,694,616
Ensembl chr 3:40,637,427...40,695,177
JBrowse link
G CAMK2N1 calcium/calmodulin dependent protein kinase II inhibitor 1 ISO associated with colon cancer RGD PMID:22020760 RGD:15097511 NCBI chr 6:78,730,204...78,734,232
Ensembl chr 6:78,730,206...78,733,740
JBrowse link
G CCL2 chemokine (C-C motif) ligand 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
JBrowse link
G CCL4 C-C motif chemokine ligand 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr12:39,479,190...39,480,511
Ensembl chr12:39,478,882...39,481,082
JBrowse link
G CDA cytidine deaminase ISO DNA:SNP:cds:rs1048977|rs12726436|rs2072671 (human) RGD PMID:28347776 RGD:152995291 NCBI chr 6:78,824,248...78,849,154
Ensembl chr 6:78,824,270...78,849,547
JBrowse link
G CLU clusterin ISO CTD Direct Evidence: marker/mechanism CTD PMID:24361871 PMID:28885000 NCBI chr14:11,336,585...11,352,569
Ensembl chr14:11,336,595...11,349,764
JBrowse link
G COMMD1 copper metabolism domain containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23583003 NCBI chr 3:79,770,315...79,913,969
Ensembl chr 3:79,770,463...79,913,975
JBrowse link
G CP ceruloplasmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr13:89,396,713...89,463,540
Ensembl chr13:89,396,708...89,463,476
JBrowse link
G CSF2 colony stimulating factor 2 ISO CTD Direct Evidence: therapeutic CTD PMID:7960606 NCBI chr 2:134,354,724...134,357,155
Ensembl chr 2:134,354,724...134,357,155
JBrowse link
G CSF3 colony stimulating factor 3 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:7692001 PMID:27737899 PMID:31557154 NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
JBrowse link
G CST3 cystatin C ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr17:30,471,056...30,474,486
Ensembl chr17:30,470,855...30,474,590
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10445756 NCBI chr 7:58,779,529...58,786,155
Ensembl chr 7:58,779,475...58,786,100
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23609392 NCBI chr 5:6,539,021...6,543,643
Ensembl chr 5:6,538,907...6,543,642
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18990727 NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
JBrowse link
G DHFR dihydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr 2:89,230,660...89,255,830 JBrowse link
G DIP2B disco interacting protein 2 homolog B ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 5:16,373,027...16,603,460
Ensembl chr 5:16,373,042...16,603,164
JBrowse link
G DPYD dihydropyrimidine dehydrogenase ISO DNA:SNP:cds:rs12119882 (human) RGD PMID:28347776 RGD:152995291 NCBI chr 4:119,931,471...120,712,461
Ensembl chr 4:119,931,414...120,712,459
JBrowse link
G ENOSF1 enolase superfamily member 1 ISO DNA:SNP:cds:rs699517 (human) RGD PMID:28347776 RGD:152995291 NCBI chr 6:105,613,211...105,642,533
Ensembl chr 6:105,613,215...105,645,113
JBrowse link
G EPHA7 EPH receptor A7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30357299 NCBI chr 1:60,771,567...60,944,092
Ensembl chr 1:60,771,572...60,944,038
JBrowse link
G EPHX2 epoxide hydrolase 2 ISO CTD Direct Evidence: therapeutic CTD PMID:26165641 NCBI chr14:11,217,125...11,293,018
Ensembl chr14:11,216,978...11,293,410
JBrowse link
G ERCC1 ERCC excision repair 1, endonuclease non-catalytic subunit treatment ISO associated with Breast Neoplasms;DNA:SNP: :p.Q504K (human)
associated with Leukemia, Myeloid, Acute
RGD PMID:17197435 PMID:25495407 RGD:11252168 RGD:11252178 NCBI chr 6:51,783,537...51,808,898
Ensembl chr 6:51,783,478...51,798,984
JBrowse link
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit treatment ISO DNA:SNP: :p.K751Q (rs13181) (human)
associated with Leukemia, Myeloid, Acute;DNA:SNPs, haplotypes: :p.D312N, p.K751Q (human)
RGD PMID:15339847 PMID:17197435 RGD:11252178 RGD:11252202 NCBI chr 6:51,734,318...51,757,508
Ensembl chr 6:51,734,320...51,757,553
JBrowse link
G FGA fibrinogen alpha chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 8:74,574,870...74,584,202
Ensembl chr 8:74,574,882...74,584,202
JBrowse link
G FNDC3B fibronectin type III domain containing 3B ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr13:110,587,464...110,931,687
Ensembl chr13:110,587,463...110,928,465
JBrowse link
G GATA4 GATA binding protein 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31190750 NCBI chr14:14,858,470...14,938,156
Ensembl chr14:14,884,662...14,939,941
JBrowse link
G GATA6 GATA binding protein 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31190750 NCBI chr 6:107,282,709...107,314,725
Ensembl chr 6:107,282,849...107,314,626
JBrowse link
G GC GC vitamin D binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 PMID:24361871 PMID:28885000 NCBI chr16:66,162,318...66,208,868 JBrowse link
G HMGB1 high mobility group box 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27474498 NCBI chr11:7,195,556...7,321,071 JBrowse link
G HMOX1 heme oxygenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18227147
G HOMER1 homer scaffold protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24126708 NCBI chr 2:88,116,664...88,253,843
Ensembl chr 2:88,122,882...88,255,281
JBrowse link
G HP haptoglobin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 6:14,980,382...14,985,245 JBrowse link
G HPX hemopexin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 9:3,288,288...3,297,051
Ensembl chr 9:3,288,172...3,297,047
JBrowse link
G HSPB6 heat shock protein family B (small) member 6 ISO CTD Direct Evidence: therapeutic CTD PMID:18948619 NCBI chr 6:45,181,439...45,184,011
Ensembl chr 6:45,181,443...45,183,998
JBrowse link
G HTR2B 5-hydroxytryptamine receptor 2B ISO CTD Direct Evidence: marker/mechanism CTD PMID:16863450 NCBI chr15:131,844,578...131,860,417
Ensembl chr15:131,844,992...131,859,277
JBrowse link
G IFNG interferon gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
JBrowse link
G IGF1 insulin like growth factor 1 ISO CTD Direct Evidence: therapeutic CTD PMID:20064577 NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
JBrowse link
G IGFBP1 insulin like growth factor binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr18:50,018,487...50,022,799
Ensembl chr18:50,018,487...50,022,799
JBrowse link
G IL10 interleukin 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
JBrowse link
G IL1RN interleukin 1 receptor antagonist ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154
G IL6 interleukin 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
JBrowse link
G KITLG KIT ligand ISO CTD Direct Evidence: therapeutic CTD PMID:1720698 NCBI chr 5:94,016,992...94,110,219
Ensembl chr 5:94,017,387...94,110,214
JBrowse link
G LCN2 lipocalin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 1:268,609,975...268,614,651
Ensembl chr 1:268,609,887...268,614,644
JBrowse link
G LOC100511905 arylamine N-acetyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11505221 NCBI chr17:13,383,478...13,393,287 JBrowse link
G LTBR lymphotoxin beta receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 5:64,271,372...64,278,422
Ensembl chr 5:64,270,310...64,287,523
JBrowse link
G MAPK14 mitogen-activated protein kinase 14 susceptibility ISO associated with lung non-small cell carcinoma;DNA:SNP:3' utr, intron: (rs3804451) (human) RGD PMID:26993769 RGD:151665351 NCBI chr 7:31,791,398...31,861,544
Ensembl chr 7:31,790,877...31,862,031
JBrowse link
G MOCOS molybdenum cofactor sulfurase ISO CTD Direct Evidence: marker/mechanism CTD PMID:29935280 NCBI chr 6:119,945,076...120,018,332
Ensembl chr 6:119,945,052...120,018,097
JBrowse link
G MT-ATP8 mitochondrially encoded ATP synthase membrane subunit 8 ISO ClinVar Annotator: match by term: Brain pseudoatrophy, reversible, valproate-induced, susceptibility to ClinVar PMID:9243242 PMID:17101920 NCBI chr MT:8,959...9,162
Ensembl chr MT:8,959...9,162
JBrowse link
G MTHFR methylenetetrahydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15753437 PMID:16166815 PMID:17387702 PMID:17502830 PMID:18551038 More... NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
JBrowse link
G MTR 5-methyltetrahydrofolate-homocysteine methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15753437 PMID:19159907 NCBI chr14:54,546,978...54,652,780
Ensembl chr14:54,546,978...54,652,763
JBrowse link
G MTRR 5-methyltetrahydrofolate-homocysteine methyltransferase reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr16:74,245,214...74,270,828
Ensembl chr16:74,245,228...74,270,783
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 ISO CTD Direct Evidence: therapeutic CTD PMID:20605904 NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
JBrowse link
G NR3C1 nuclear receptor subfamily 3 group C member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29802709 NCBI chr 2:144,822,937...144,956,451
Ensembl chr 2:144,822,939...144,956,451
JBrowse link
G NT5C2 5'-nucleotidase, cytosolic II ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr14:114,062,451...114,167,460
Ensembl chr14:114,062,459...114,145,109
JBrowse link
G ORM1 orosomucoid 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 1:254,939,154...254,943,065 JBrowse link
G PELI1 pellino E3 ubiquitin protein ligase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 3:77,740,460...77,796,911
Ensembl chr 3:77,713,489...77,796,914
JBrowse link
G PLG plasminogen ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 1:7,062,399...7,109,521
Ensembl chr 1:7,061,192...7,110,555
JBrowse link
G PLK2 polo like kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12897130 NCBI chr16:37,299,116...37,305,114
Ensembl chr16:37,299,119...37,305,114
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:19683050 NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10698006 NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
JBrowse link
G REN renin ISO CTD Direct Evidence: marker/mechanism CTD PMID:8723173 NCBI chr 9:64,809,143...64,822,605
Ensembl chr 9:64,809,146...64,822,658
JBrowse link
G SERPINA1 serpin family A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 7:115,604,282...115,616,915
Ensembl chr 7:115,583,043...115,614,645
JBrowse link
G SHMT1 serine hydroxymethyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr12:60,414,421...60,435,451
Ensembl chr12:60,416,463...60,435,450
JBrowse link
G SLA-3 MHC class I antigen 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19629158 NCBI chr 7:22,938,211...22,942,735 JBrowse link
G SLC19A1 solute carrier family 19 member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr13:207,986,094...208,007,855
Ensembl chr13:207,986,098...208,007,675
JBrowse link
G SLC22A7 solute carrier family 22 member 7 ISO DNA:SNP:cds:rs2270860|rs4149178 (human) RGD PMID:28347776 RGD:152995291 NCBI chr 7:38,328,474...38,334,879
Ensembl chr 7:38,328,419...38,334,878
JBrowse link
G SLC34A2 solute carrier family 34 member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 8:19,481,127...19,507,903
Ensembl chr 8:19,481,198...19,509,666
JBrowse link
G SLCO2A1 solute carrier organic anion transporter family member 2A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr13:75,108,540...75,189,660
Ensembl chr13:75,106,607...75,190,022
JBrowse link
G SOD1 superoxide dismutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
JBrowse link
G TCN2 transcobalamin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15753437 NCBI chr14:47,496,245...47,515,966
Ensembl chr14:47,502,715...47,515,965
JBrowse link
G TF transferrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr13:74,930,655...74,970,599
Ensembl chr13:74,930,655...74,972,763
JBrowse link
G THBD thrombomodulin ISO CTD Direct Evidence: therapeutic CTD PMID:27474498 NCBI chr17:30,219,870...30,223,499
Ensembl chr17:30,217,303...30,224,099
JBrowse link
G TLR1 toll like receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr 8:30,147,600...30,155,454
Ensembl chr 8:30,147,624...30,155,466
JBrowse link
G TLR2 toll like receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 PMID:31557154 NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
JBrowse link
G TOP1 DNA topoisomerase I ISO CTD Direct Evidence: marker/mechanism CTD PMID:19931604 NCBI chr17:43,710,270...43,799,700
Ensembl chr17:43,710,290...43,799,700
JBrowse link
G TP53 tumor protein p53 ISO CTD Direct Evidence: marker/mechanism CTD PMID:9369336 NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
JBrowse link
G TTR transthyretin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,326...115,503,977
JBrowse link
G TXN thioredoxin ISO CTD Direct Evidence: therapeutic CTD PMID:11462148 NCBI chr 1:251,264,180...251,278,000
Ensembl chr 1:251,263,175...251,277,988
JBrowse link
G TYMS thymidylate synthetase ISO CTD Direct Evidence: marker/mechanism
DNA:SNP:cds:rs2853741 (human)
CTD
RGD
PMID:19648163 PMID:21064136 PMID:25007187 PMID:26077125 PMID:28347776 RGD:152995291 NCBI chr 6:105,642,730...105,660,279
Ensembl chr 6:105,642,381...105,660,578
JBrowse link
G UMPS uridine monophosphate synthetase ISO DNA:SNP:cds:rs2279199|rs4678145 (human) RGD PMID:28347776 RGD:152995291 NCBI chr13:135,611,857...135,650,656
Ensembl chr13:135,610,058...135,650,603
JBrowse link
G VEGFA vascular endothelial growth factor A ISO CTD Direct Evidence: marker/mechanism CTD PMID:31068094 NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
JBrowse link
G VKORC1 vitamin K epoxide reductase complex subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26445138 NCBI chr 3:17,386,230...17,389,162
Ensembl chr 3:17,386,245...17,389,905
JBrowse link
Anthracycline-induced Cardiotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 susceptibility ISO DNA:missense mutation:cds:p.G671V (human) RGD PMID:16330681 RGD:11041175 NCBI chr 9:93,049,955...93,146,469 JBrowse link
G ACVR2B activin A receptor type 2B treatment ISO human construct in mouse model RGD PMID:30765322 RGD:329849112 NCBI chr13:23,237,699...23,276,086
Ensembl chr13:23,237,699...23,267,373
JBrowse link
G CAPN2 calpain 2 treatment ISO RGD PMID:25634181 RGD:13792617 NCBI chr10:19,758,824...19,820,241
Ensembl chr10:19,758,757...19,820,246
JBrowse link
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit ISO associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human) RGD PMID:24284041 RGD:11252190 NCBI chr 6:51,734,318...51,757,508
Ensembl chr 6:51,734,320...51,757,553
JBrowse link
aspirin-induced respiratory disease term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CACNG6 calcium voltage-gated channel auxiliary subunit gamma 6 susceptibility ISO DNA:SNP,haplotype:rs192808(human) RGD PMID:20860846 RGD:13524562 NCBI chr 6:56,123,598...56,151,145
Ensembl chr 6:56,129,834...56,151,133
JBrowse link
G CCR2 C-C motif chemokine receptor 2 ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:20022477 PMID:20485159 RGD:4145619 NCBI chr13:29,251,950...29,286,470
Ensembl chr13:29,285,012...29,376,343
JBrowse link
G CYSLTR1 cysteinyl leukotriene receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 PMID:17641958 PMID:20485159 NCBI chr  X:62,380,778...62,407,736
Ensembl chr  X:62,380,780...62,456,689
JBrowse link
G CYSLTR2 cysteinyl leukotriene receptor 2 ISO CTD Direct Evidence: marker/mechanism
DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human)
CTD
RGD
PMID:15970796 PMID:16502481 PMID:20485159 RGD:5144000 NCBI chr11:18,988,665...19,011,015
Ensembl chr11:18,987,174...19,011,015
JBrowse link
G FANCC FA complementation group C ISO DNA:haplotype::rs4647416(human) RGD PMID:21670957 RGD:11045795 NCBI chr10:26,796,546...27,055,271
Ensembl chr10:26,796,572...27,061,801
JBrowse link
G IL4 interleukin 4 susceptibility ISO DNA:SNPs:promoter,5'UTR,intron:multiple RGD PMID:20921925 RGD:11528633 NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
JBrowse link
G LTC4S leukotriene C4 synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 NCBI chr 2:78,799,446...78,802,281
Ensembl chr 2:78,799,449...78,802,285
JBrowse link
G MS4A2 membrane spanning 4-domains A2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr 2:11,400,415...11,420,314
Ensembl chr 2:11,400,420...11,420,298
JBrowse link
G POSTN periostin ISO CTD Direct Evidence: marker/mechanism CTD PMID:18391768 NCBI chr11:13,225,183...13,258,973
Ensembl chr11:13,224,959...13,258,978
JBrowse link
G PTGDR2 prostaglandin D2 receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 2:10,891,280...10,897,194
Ensembl chr 2:10,892,011...10,903,017
JBrowse link
G PTGER2 prostaglandin E receptor 2 ISO ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to ClinVar PMID:15496426 NCBI chr 1:181,993,961...182,009,959
Ensembl chr 1:181,994,560...182,009,953
JBrowse link
G PTGIR prostaglandin I2 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 6:52,522,639...52,527,338
Ensembl chr 6:52,522,638...52,527,345
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 ISO protein:increased expression:mast cell
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:9487340 PMID:16502481 PMID:20485159 RGD:5143936 NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
JBrowse link
G TAP2 transporter 2, ATP binding cassette subfamily B member ISO RGD PMID:21796142 RGD:5147839 NCBI chr 7:25,045,085...25,056,915
Ensembl chr 7:25,045,685...25,056,300
JBrowse link
G TBX21 T-box transcription factor 21 ISO ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to ClinVar PMID:15806396 NCBI chr12:23,996,415...24,009,353
Ensembl chr12:23,996,415...24,009,355
JBrowse link
G TBXA2R thromboxane A2 receptor susceptibility ISO DNA:polymorphism: :795T>C (human)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:15898979 PMID:16502481 PMID:20485159 RGD:11059537 NCBI chr 2:75,068,413...75,081,305
Ensembl chr 2:75,068,698...75,087,731
JBrowse link
asthma, nasal polyps, and aspirin intolerance term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX15 arachidonate 15-lipoxygenase ISO ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance ClinVar PMID:17959182 PMID:21558275 PMID:30643255 NCBI chr12:52,287,174...52,295,873
Ensembl chr12:52,287,160...52,295,871
JBrowse link
G PTGER2 prostaglandin E receptor 2 susceptibility ISO CTD Direct Evidence: marker/mechanism OMIM
CTD
NCBI chr 1:181,993,961...182,009,959
Ensembl chr 1:181,994,560...182,009,953
JBrowse link
G TBX21 T-box transcription factor 21 susceptibility ISO ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance ClinVar
OMIM
PMID:25741868 NCBI chr12:23,996,415...24,009,353
Ensembl chr12:23,996,415...24,009,355
JBrowse link
Cardiotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACACB acetyl-CoA carboxylase beta ISO mRNA, protein:increased expression:heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr14:41,621,574...41,739,916
Ensembl chr14:41,621,574...41,739,916
JBrowse link
G AGT angiotensinogen ISO CTD Direct Evidence: marker/mechanism CTD PMID:33676887 NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
JBrowse link
G BCHE butyrylcholinesterase ISO CTD Direct Evidence: therapeutic CTD PMID:26145887 NCBI chr13:104,946,732...105,007,568 JBrowse link
G BMP2 bone morphogenetic protein 2 ISO CTD Direct Evidence: therapeutic CTD PMID:29800642 NCBI chr17:15,750,487...15,762,982
Ensembl chr17:15,749,835...15,761,195
JBrowse link
G CAT catalase ISO CTD Direct Evidence: therapeutic CTD PMID:35792220 NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
JBrowse link
G CCL2 chemokine (C-C motif) ligand 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
JBrowse link
G CPT1A carnitine palmitoyltransferase 1A ISO mRNA, protein:decreased expression:heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr 2:4,250,642...4,293,914
Ensembl chr 2:4,233,099...4,293,911
JBrowse link
G CSF1 colony stimulating factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32068018 NCBI chr 4:110,178,466...110,198,232
Ensembl chr 4:110,178,475...110,197,900
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
JBrowse link
G FAS Fas cell surface death receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:34713381 NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
JBrowse link
G FASLG Fas ligand ISO CTD Direct Evidence: marker/mechanism CTD PMID:34713381 NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
JBrowse link
G FTO FTO alpha-ketoglutarate dependent dioxygenase ISO DNA:hypermethylation:promoter RGD PMID:35462195 RGD:329951017 NCBI chr 6:31,177,112...31,564,674
Ensembl chr 6:31,174,569...31,564,718
JBrowse link
G HBEGF heparin binding EGF like growth factor ISO CTD Direct Evidence: therapeutic CTD PMID:29305325 NCBI chr 2:142,102,455...142,115,192
Ensembl chr 2:142,102,458...142,115,174
JBrowse link
G LOC110258578 interleukin-1 beta-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:32068018
G METTL14 methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:34648132 NCBI chr 8:105,019,539...105,053,603
Ensembl chr 8:105,015,420...105,053,563
JBrowse link
G MIR143 microRNA mir-143 ameliorates ISO RGD PMID:32170053 RGD:155883163 NCBI chr 2:150,578,738...150,578,817
Ensembl chr 2:150,578,738...150,578,817
JBrowse link
G MLYCD malonyl-CoA decarboxylase ISO protein:increased expression:heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr 6:4,683,386...4,698,698
Ensembl chr 6:4,681,664...4,698,661
JBrowse link
G NOS3 nitric oxide synthase 3 treatment ISO associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human) RGD PMID:26345518 RGD:11533645 NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
JBrowse link
G NPPB natriuretic peptide B ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 6:71,930,374...71,931,843
Ensembl chr 6:71,930,382...71,932,254
JBrowse link
G NRG1 neuregulin 1 ISO CTD Direct Evidence: therapeutic CTD PMID:29305325 NCBI chr15:52,625,550...53,688,003
Ensembl chr15:52,630,679...52,839,505
JBrowse link
G PRKAA2 protein kinase AMP-activated catalytic subunit alpha 2 ISO protein:decreased expression:serum, heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr 6:155,683,392...155,754,283
Ensembl chr 6:155,681,784...155,754,278
JBrowse link
G RAC1 Rac family small GTPase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28710503 NCBI chr 3:4,781,776...4,803,510
Ensembl chr 3:4,781,780...4,803,543
JBrowse link
G RARG retinoic acid receptor gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:26237429 NCBI chr 5:18,436,267...18,458,625
Ensembl chr 5:18,436,270...18,458,624
JBrowse link
G RNF10 ring finger protein 10 ISO CTD Direct Evidence: therapeutic CTD PMID:36740146 NCBI chr14:40,481,239...40,521,998
Ensembl chr14:40,481,249...40,519,886
JBrowse link
G SIRT6 sirtuin 6 ISO CTD Direct Evidence: therapeutic CTD PMID:34713381 NCBI chr 2:74,568,539...74,577,774
Ensembl chr 2:74,568,493...74,577,772
JBrowse link
G TLR2 toll like receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 8:75,416,257...75,428,370
Ensembl chr 8:75,411,993...75,428,330
JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 PMID:32068018 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
JBrowse link
G TP53 tumor protein p53 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30009776 PMID:34713381 NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
JBrowse link
Chemical and Drug Induced Liver Injury term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AASS aminoadipate-semialdehyde synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr18:24,938,366...25,039,197
Ensembl chr18:24,974,754...25,039,195
JBrowse link
G ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 severity
susceptibility
ISO CTD Direct Evidence: marker/mechanism
DNA:SNP::2677G>T/A(rs2032582)(human)
CTD
RGD
PMID:20623750 PMID:26134275 PMID:27296832 RGD:11041130 RGD:14700895 NCBI chr 9:93,049,955...93,146,469 JBrowse link
G ABCB11 ATP binding cassette subfamily B member 11 severity ISO DNA:SNP: :rs2287616(human) RGD PMID:27293027 RGD:14402413 NCBI chr15:75,402,296...75,487,092
Ensembl chr15:75,402,396...75,486,403
JBrowse link
G ABCC1 ATP binding cassette subfamily C member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr 3:28,360,868...28,472,940
Ensembl chr 3:28,360,873...28,473,456
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 susceptibility ISO CTD Direct Evidence: marker/mechanism
DNA:polymorphism:promoter:-24C>T(human)
CTD
RGD
PMID:17241877 PMID:18381794 PMID:18466103 PMID:25196354 RGD:14700812 RGD:14700814 NCBI chr14:110,955,698...111,038,898
Ensembl chr14:110,955,633...111,037,537
JBrowse link
G ABI1 abl interactor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:48,939,407...49,069,269
Ensembl chr10:48,939,446...49,069,441
JBrowse link
G ACE angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 ISO mRNA:increased expression:liver (rat) RGD PMID:25143335 RGD:25671447 NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
JBrowse link
G ACOX3 acyl-CoA oxidase 3, pristanoyl ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 8:2,716,913...2,756,221
Ensembl chr 8:2,716,918...2,770,801
JBrowse link
G ACSL1 acyl-CoA synthetase long chain family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:45,866,858...45,936,327
Ensembl chr15:45,866,857...45,963,729
JBrowse link
G ACTB actin beta ISO mRNA:increased expression:liver
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:22563491 PMID:25231249 RGD:9587759 NCBI chr 3:4,084,275...4,090,383
Ensembl chr 3:4,082,216...4,090,356
JBrowse link
G ACTN4 actinin alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:47,493,834...47,565,999
Ensembl chr 6:47,493,919...47,565,998
JBrowse link
G ACTR3 actin related protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:20,104,808...20,171,721
Ensembl chr15:20,104,812...20,167,421
JBrowse link
G ADA adenosine deaminase ISO protein:increased expression:liver RGD PMID:21161045 RGD:5128859 NCBI chr17:47,044,492...47,072,232
Ensembl chr17:47,044,497...47,072,245
JBrowse link
G ADAM8 ADAM metallopeptidase domain 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24646716 NCBI chr14:141,221,177...141,233,728
Ensembl chr14:141,221,198...141,232,306
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing ISO CTD Direct Evidence: therapeutic CTD PMID:20709802 NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
JBrowse link
G ADIPOR2 adiponectin receptor 2 severity ISO associated with obesity, LPS;mRNA:decreased expression:liver (rat) RGD PMID:23838384 RGD:8695926 NCBI chr 5:68,755,789...68,807,247
Ensembl chr 5:68,755,811...68,807,235
JBrowse link
G ADORA2B adenosine A2b receptor ISO CTD Direct Evidence: therapeutic CTD PMID:35292334 NCBI chr12:59,431,834...59,449,701
Ensembl chr12:59,431,513...59,449,672
JBrowse link
G AGT angiotensinogen ISO CTD Direct Evidence: marker/mechanism CTD PMID:29499335 NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
JBrowse link
G AHR aryl hydrocarbon receptor ISO CTD Direct Evidence: marker/mechanism|therapeutic
mRNA:decreased expression:liver (rat)
CTD
RGD
PMID:21890736 PMID:28959666 PMID:34848246 RGD:401794432 NCBI chr 9:86,511,866...86,555,950
Ensembl chr 9:86,511,369...86,555,943
JBrowse link
G AIFM1 apoptosis inducing factor mitochondria associated 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25743375 NCBI chr  X:106,676,596...106,708,290
Ensembl chr  X:106,670,520...106,708,317
JBrowse link
G AK4 adenylate kinase 4 ISO protein:increased expression:liver (rat) RGD PMID:16538043 RGD:2301096 NCBI chr 6:147,177,029...147,257,799
Ensembl chr 6:147,177,029...147,257,814
JBrowse link
G AKR1A1 aldo-keto reductase family 1 member A1 ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:29763686 PMID:32805337 RGD:27226688 NCBI chr 6:165,811,245...165,825,168
Ensembl chr 6:165,811,247...165,824,896
JBrowse link
G ALB albumin treatment ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:18779383 PMID:22310181 PMID:27567545 RGD:14694844 NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696
JBrowse link
G ALDH1L2 aldehyde dehydrogenase 1 family member L2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:79,492,672...79,558,702
Ensembl chr 5:79,492,750...79,558,701
JBrowse link
G ALDH2 aldehyde dehydrogenase 2 family member susceptibility
severity
ISO protein:increased expression:liver
DNA:deletion:exon 3 (mouse)
RGD PMID:21138988 PMID:24492981 PMID:30121625 RGD:14975148 RGD:15036810 RGD:7241599 NCBI chr14:39,902,317...39,933,113
Ensembl chr14:39,896,565...39,933,124
JBrowse link
G ALDH9A1 aldehyde dehydrogenase 9 family member A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:85,029,914...85,057,650 JBrowse link
G ALDOB aldolase, fructose-bisphosphate B ISO CTD Direct Evidence: marker/mechanism CTD PMID:16115720 NCBI chr 1:243,127,870...243,141,504
Ensembl chr 1:243,110,585...243,141,418
JBrowse link
G AMBP alpha-1-microglobulin/bikunin precursor ISO CTD Direct Evidence: marker/mechanism CTD PMID:18779383 NCBI chr 1:254,683,885...254,703,220
Ensembl chr 1:254,683,891...254,703,225
JBrowse link
G ANXA2 annexin A2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:111,588,721...111,635,064
Ensembl chr 1:111,588,306...111,635,059
JBrowse link
G ANXA6 annexin A6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr16:71,857,229...71,913,723
Ensembl chr16:71,857,258...71,913,723
JBrowse link
G APOA1 apolipoprotein A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 9:44,216,481...44,218,360
Ensembl chr 9:44,216,392...44,218,713
JBrowse link
G APOE apolipoprotein E ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330
JBrowse link
G APOH apolipoprotein H ISO mRNA:increased expression:plasma:
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:16099942 PMID:23288050 RGD:10054107 NCBI chr12:12,827,195...12,839,172
Ensembl chr12:12,827,201...12,839,175
JBrowse link
G ARG1 arginase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22872058 NCBI chr 1:32,006,035...32,028,983
Ensembl chr 1:32,006,046...32,028,988
JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator ISO CTD Direct Evidence: marker/mechanism CTD PMID:20935161 NCBI chr 4:98,333,431...98,390,012
Ensembl chr 4:98,333,459...98,389,457
JBrowse link
G ARNTL aryl hydrocarbon receptor nuclear translocator like ISO CTD Direct Evidence: therapeutic CTD PMID:36602574 NCBI chr 2:45,895,637...46,025,174
Ensembl chr 2:45,895,289...45,988,570
JBrowse link
G ATG5 autophagy related 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22491424 NCBI chr 1:72,343,950...72,520,402
Ensembl chr 1:72,270,799...72,520,396
JBrowse link
G ATOH8 atonal bHLH transcription factor 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:58,964,541...59,001,620
Ensembl chr 3:58,964,550...59,001,145
JBrowse link
G ATP6V1D ATPase H+ transporting V1 subunit D ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:91,065,998...91,084,908
Ensembl chr 7:91,064,396...91,084,913
JBrowse link
G BAD BCL2 associated agonist of cell death treatment ISO RGD PMID:25447754 RGD:10053709 NCBI chr 2:7,831,192...7,842,864
Ensembl chr 2:7,830,920...7,842,863
JBrowse link
G BAX BCL2 associated X, apoptosis regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:17906064 NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140
JBrowse link
G BDH1 3-hydroxybutyrate dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr13:132,602,372...132,647,271
Ensembl chr13:132,605,489...132,645,937
JBrowse link
G BDKRB2 bradykinin receptor B2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30685357 NCBI chr 7:117,438,622...117,472,005
Ensembl chr 7:117,438,713...117,472,005
JBrowse link
G BLVRB biliverdin reductase B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:48,715,540...48,728,433
Ensembl chr 6:48,715,199...48,728,389
JBrowse link
G BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:9,659,876...9,684,115
Ensembl chr10:9,659,487...9,683,912
JBrowse link
G BRD4 bromodomain containing 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:62,250,958...62,345,851
Ensembl chr 2:62,250,989...62,345,362
JBrowse link
G BTD biotinidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15469856 NCBI chr13:2,840,425...2,902,619
Ensembl chr13:2,840,456...2,959,846
JBrowse link
G C3 complement C3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
JBrowse link
G CA3 carbonic anhydrase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 PMID:25231249 NCBI chr 4:51,227,485...51,237,861
Ensembl chr 4:51,227,485...51,237,844
JBrowse link
G CABP1 calcium binding protein 1 ISO protein:increased expression:liver RGD PMID:21138988 RGD:7241599 NCBI chr14:40,563,302...40,587,975
Ensembl chr14:40,563,159...40,587,970
JBrowse link
G CADPS2 calcium dependent secretion activator 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr18:24,372,547...24,867,287
Ensembl chr18:24,372,544...24,867,482
JBrowse link
G CANX calnexin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:78,879,031...78,915,828
Ensembl chr 2:78,879,033...78,915,827
JBrowse link
G CAP1 cyclase associated actin cytoskeleton regulatory protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:95,811,485...95,840,576
Ensembl chr 6:95,812,179...95,840,570
JBrowse link
G CASP8 caspase 8 treatment ISO RGD PMID:25447754 RGD:10053709 NCBI chr15:104,923,659...104,948,470
Ensembl chr15:104,923,953...104,948,468
JBrowse link
G CAST calpastatin ISO RGD PMID:16871587 RGD:5683869 NCBI chr 2:103,255,738...103,378,623
Ensembl chr 2:103,255,750...103,378,623
JBrowse link
G CAT catalase ISO CTD Direct Evidence: marker/mechanism
protein:decreased expression:liver
CTD
RGD
PMID:20623750 PMID:21138988 PMID:25231249 RGD:7241599 NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
JBrowse link
G CCDC80 coiled-coil domain containing 80 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr13:147,203,333...147,244,753
Ensembl chr13:147,207,598...147,245,994
JBrowse link
G CCL2 chemokine (C-C motif) ligand 2 treatment ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:20623750 PMID:21813474 PMID:30663942 RGD:14995458 RGD:14995466 NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
JBrowse link
G CCR2 C-C motif chemokine receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr13:29,368,735...29,374,564
Ensembl chr13:29,285,012...29,376,343
JBrowse link
G CCR5 C-C motif chemokine receptor 5 susceptibility ISO acetaminophen RGD PMID:24770590 RGD:14401733 NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
JBrowse link
G CCT3 chaperonin containing TCP1 subunit 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:93,733,967...93,753,340
Ensembl chr 4:93,733,918...93,753,340
JBrowse link
G CCT5 chaperonin containing TCP1 subunit 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr16:72,211,452...72,223,202
Ensembl chr16:72,208,012...72,223,114
JBrowse link
G CDC25B cell division cycle 25B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr17:31,910,824...31,929,418
Ensembl chr17:31,910,825...31,929,242
JBrowse link
G CDS1 CDP-diacylglycerol synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 8:133,959,250...134,041,258
Ensembl chr 8:133,959,247...134,041,258
JBrowse link
G CELA1 chymotrypsin like elastase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513
G CFAP20 cilia and flagella associated protein 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:19,954,698...19,969,383
Ensembl chr 6:19,954,925...19,969,347
JBrowse link
G CFH complement factor H ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249
G CHRM3 cholinergic receptor muscarinic 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20197374 NCBI chr14:51,818,625...52,363,662
Ensembl chr14:51,828,231...51,830,003
JBrowse link
G CKB creatine kinase B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249
G CLU clusterin ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr14:11,336,585...11,352,569
Ensembl chr14:11,336,595...11,349,764
JBrowse link
G COL14A1 collagen type XIV alpha 1 chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:18,690,197...18,925,111
Ensembl chr 4:18,690,198...18,924,971
JBrowse link
G COL3A1 collagen type III alpha 1 chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:16679477 NCBI chr15:93,556,914...93,595,678
Ensembl chr15:93,526,603...93,596,363
JBrowse link
G COMT catechol-O-methyltransferase ISO protein:decreased expression:liver RGD PMID:21138988 RGD:7241599 NCBI chr14:51,384,729...51,403,997
Ensembl chr14:51,385,738...51,403,998
JBrowse link
G COQ9 coenzyme Q9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:19,373,052...19,390,738
Ensembl chr 6:19,372,711...19,390,820
JBrowse link
G CP ceruloplasmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr13:89,396,713...89,463,540
Ensembl chr13:89,396,708...89,463,476
JBrowse link
G CPB2 carboxypeptidase B2 ISO mRNA,protein:increased expression,increased activity:liver,plasma RGD PMID:19386599 RGD:7243112 NCBI chr11:21,234,447...21,298,250
Ensembl chr11:21,234,447...21,298,241
JBrowse link
G CPS1 carbamoyl-phosphate synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:113,210,038...113,339,086
Ensembl chr15:113,150,157...113,339,078
JBrowse link
G CPT1A carnitine palmitoyltransferase 1A ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr 2:4,250,642...4,293,914
Ensembl chr 2:4,233,099...4,293,911
JBrowse link
G CRP C-reactive protein, pentraxin-related ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
JBrowse link
G CSF3 colony stimulating factor 3 ISO CTD Direct Evidence: therapeutic CTD PMID:20005281 NCBI chr12:22,333,445...22,335,949
Ensembl chr12:22,333,449...22,338,753
JBrowse link
G CTNNB1 catenin beta 1 ISO CTD Direct Evidence: therapeutic CTD PMID:19679878 NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311
JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 ISO CTD Direct Evidence: therapeutic CTD PMID:11739529 NCBI chr 8:71,693,641...71,695,948
Ensembl chr 8:71,693,339...71,695,948
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33814510 NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28762043 NCBI chr 7:58,779,529...58,786,155
Ensembl chr 7:58,779,475...58,786,100
JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33814510 NCBI chr 3:102,195,743...102,205,687
Ensembl chr 3:102,195,741...102,205,683
JBrowse link
G CYP27B1 cytochrome P450 family 27 subfamily B member 1 ISO mRNA, protein:decreased expression:kidney (mouse) RGD PMID:26476181 RGD:25671412 NCBI chr 5:23,053,129...23,058,865
Ensembl chr 5:23,053,892...23,058,470
JBrowse link
G CYP2B6B cytochrome P450 family 2 subfamily B member 6B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28762043 PMID:33814510 NCBI chr 6:49,158,175...49,173,872
Ensembl chr 6:49,110,812...49,178,334
JBrowse link
G CYP2C49 cytochrome P450 2C49 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12963435 PMID:28762043 NCBI chr14:106,571,803...106,612,082
Ensembl chr14:106,285,173...106,612,455
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 ISO DNA:hypermethylation:promoter RGD PMID:27490558 RGD:14700879 NCBI chr 5:6,539,021...6,543,643
Ensembl chr 5:6,538,907...6,543,642
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 treatment ISO CTD Direct Evidence: marker/mechanism
associated with Endotoxemia
DNA:hypermethylation:promoter
CTD
RGD
PMID:12668988 PMID:16770646 PMID:21741958 PMID:25681370 PMID:27324775 More... RGD:14700872 RGD:14700873 RGD:14700878 RGD:14700879 RGD:14700901 NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
JBrowse link
G CYP8B1 cytochrome P450 family 8 subfamily B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25448281 NCBI chr13:26,330,233...26,331,738
Ensembl chr13:26,330,233...26,331,738
JBrowse link
G DBT dihydrolipoamide branched chain transacylase E2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:117,884,657...117,924,006
Ensembl chr 4:117,875,002...117,936,612
JBrowse link
G DDB1 damage specific DNA binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:10,171,554...10,201,602
Ensembl chr 2:10,171,502...10,201,598
JBrowse link
G DGAT2 diacylglycerol O-acyltransferase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 9:10,032,163...10,066,082
Ensembl chr 9:10,032,128...10,068,437
JBrowse link
G DHFR dihydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19648163 NCBI chr 2:89,230,660...89,255,830 JBrowse link
G DHRS7 dehydrogenase/reductase 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:189,153,579...189,170,745
Ensembl chr 1:189,151,131...189,170,534
JBrowse link
G DLAT dihydrolipoamide S-acetyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:39,738,639...39,763,813
Ensembl chr 9:39,738,564...39,796,806
JBrowse link
G DNAJB9 DnaJ heat shock protein family (Hsp40) member B9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr18:36,578,928...36,584,211
Ensembl chr18:36,579,453...36,584,130
JBrowse link
G DNAJC12 DnaJ heat shock protein family (Hsp40) member C12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr14:71,005,326...71,050,397
Ensembl chr14:71,005,056...71,041,040
JBrowse link
G DSC2 desmocollin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 6:114,982,259...115,021,332
Ensembl chr 6:114,980,601...115,021,305
JBrowse link
G E2F1 E2F transcription factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr17:37,178,587...37,190,118
Ensembl chr17:37,178,599...37,189,883
JBrowse link
G ECHDC1 ethylmalonyl-CoA decarboxylase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:35,852,939...35,909,314
Ensembl chr 1:35,853,125...35,909,956
JBrowse link
G ECHS1 enoyl-CoA hydratase, short chain 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr14:141,340,320...141,348,870
Ensembl chr14:141,339,364...141,348,994
JBrowse link
G EDEM1 ER degradation enhancing alpha-mannosidase like protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr13:61,703,601...61,732,231
Ensembl chr13:61,703,621...61,732,119
JBrowse link
G EIF2AK1 eukaryotic translation initiation factor 2 alpha kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25411909 NCBI chr 3:5,075,026...5,113,390
Ensembl chr 3:5,075,054...5,113,622
JBrowse link
G EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr14:73,323,609...73,355,443
Ensembl chr14:73,323,642...73,349,291
JBrowse link
G ENDOG endonuclease G ISO protein:decreased expression:mitochondrion: RGD PMID:22509279 RGD:9685364 NCBI chr 1:269,153,955...269,157,789
Ensembl chr 1:269,154,090...269,157,788
JBrowse link
G ENG endoglin ISO protein:increased expression:liver (rat) RGD PMID:21146604 RGD:7257529 NCBI chr 1:268,309,379...268,343,861
Ensembl chr 1:268,309,400...268,343,783
JBrowse link
G ENO1 enolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 PMID:25231249 NCBI chr 6:69,385,879...69,401,664
Ensembl chr 6:69,385,879...69,401,151
JBrowse link
G ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 ISO protein:increased activity:serum: RGD PMID:17850827 RGD:9685426 NCBI chr 4:19,319,815...19,433,492
Ensembl chr 4:19,319,810...19,433,488
JBrowse link
G EPHX1 epoxide hydrolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr10:13,757,489...13,773,071
Ensembl chr10:13,751,881...13,773,072
JBrowse link
G ERLEC1 endoplasmic reticulum lectin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 3:87,362,166...87,389,814
Ensembl chr 3:87,355,904...87,389,814
JBrowse link
G ERN1 endoplasmic reticulum to nucleus signaling 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30538632 NCBI chr12:14,881,913...14,963,290
Ensembl chr12:14,881,923...14,963,284
JBrowse link
G F13A1 coagulation factor XIII A chain ISO RGD PMID:22019897 RGD:11041813 NCBI chr 7:3,751,290...3,900,797
Ensembl chr 7:3,751,292...3,900,762
JBrowse link
G F2RL3 F2R like thrombin or trypsin receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20974703 NCBI chr 2:60,742,978...60,747,014
Ensembl chr 2:60,742,996...60,744,864
JBrowse link
G F3 coagulation factor III, tissue factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:22407844 NCBI chr 4:122,827,018...122,837,673
Ensembl chr 4:122,826,644...122,837,666
JBrowse link
G FADD Fas associated via death domain treatment ISO RGD PMID:25447754 PMID:26062544 RGD:10053709 RGD:11341803 NCBI chr 2:3,191,718...3,194,820
Ensembl chr 2:3,185,675...3,194,818
JBrowse link
G FADS1 fatty acid desaturase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:9,735,425...9,747,405
Ensembl chr 2:9,735,322...9,750,506
JBrowse link
G FADS2 fatty acid desaturase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:9,633,941...9,666,666
Ensembl chr 2:9,629,423...9,735,576
JBrowse link
G FAS Fas cell surface death receptor ISO protein:increased expression:liver (rat) RGD PMID:16831245 RGD:8662853 NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
JBrowse link
G FASN fatty acid synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr12:922,405...937,560
Ensembl chr12:920,509...937,561
JBrowse link
G FCMR Fc mu receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 9:67,530,944...67,546,441
Ensembl chr 9:67,532,083...67,546,402
JBrowse link
G FGA fibrinogen alpha chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:20974703 NCBI chr 8:74,574,870...74,584,202
Ensembl chr 8:74,574,882...74,584,202
JBrowse link
G FGF21 fibroblast growth factor 21 severity ISO mRNA:increased expression:liver (rat) RGD PMID:29883717 RGD:15045603 NCBI chr 6:54,082,653...54,084,532
Ensembl chr 6:54,080,739...54,084,601
JBrowse link
G FLT1 fms related receptor tyrosine kinase 1 ISO CTD Direct Evidence: therapeutic CTD PMID:21135413 NCBI chr11:5,620,698...5,797,095
Ensembl chr11:5,621,212...5,795,264
JBrowse link
G FMO3 flavin containing dimethylaniline monoxygenase 3 ISO CTD Direct Evidence: therapeutic CTD PMID:24973094 NCBI chr 9:63,757,928...63,777,075
Ensembl chr 9:63,757,964...63,777,279
JBrowse link
G FTL ferritin light chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:54,231,121...54,232,756
Ensembl chr 6:54,231,172...54,232,750
JBrowse link
G G6PC1 glucose-6-phosphatase catalytic subunit 1 ISO mRNA:decreased expression:liver (mouse) RGD PMID:28189721 RGD:14695531 NCBI chr12:19,965,885...19,975,783
Ensembl chr12:19,965,330...19,975,857
JBrowse link
G G6PD glucose-6-phosphate dehydrogenase treatment ISO RGD PMID:21864513 RGD:10449168 NCBI chr  X:125,029,147...125,041,040
Ensembl chr  X:125,029,150...125,041,040
JBrowse link
G GADD45A growth arrest and DNA damage inducible alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 6:144,940,702...144,944,089
Ensembl chr 6:144,940,697...144,944,089
JBrowse link
G GANAB glucosidase II alpha subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:9,100,672...9,118,396
Ensembl chr 2:9,100,702...9,118,390
JBrowse link
G GC GC vitamin D binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:17573345 PMID:19481141 RGD:10402383 NCBI chr 7:27,209,565...27,253,535
Ensembl chr 7:27,209,565...27,253,530
JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:123,371,198...123,390,130
Ensembl chr 4:123,371,193...123,390,131
JBrowse link
G GDA guanine deaminase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:225,425,389...225,589,835
Ensembl chr 1:225,403,138...225,589,827
JBrowse link
G GDI1 GDP dissociation inhibitor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:124,960,835...124,966,833
Ensembl chr  X:124,960,990...124,966,832
JBrowse link
G GFER growth factor, augmenter of liver regeneration treatment ISO RGD PMID:15968720 PMID:22033404 RGD:9685722 RGD:9685727 NCBI chr 3:39,981,938...39,984,451
Ensembl chr 3:39,981,940...39,984,991
JBrowse link
G GGH gamma-glutamyl hydrolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21219404 NCBI chr 4:70,996,730...71,020,513
Ensembl chr 4:70,996,755...71,021,838
JBrowse link
G GLUD1 glutamate dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33483742 NCBI chr14:87,968,850...88,005,375
Ensembl chr14:87,968,850...88,005,520
JBrowse link
G GOT1 glutamic-oxaloacetic transaminase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:110,608,422...110,635,825
Ensembl chr14:110,608,430...110,635,874
JBrowse link
G GPD1 glycerol-3-phosphate dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:16,008,179...16,021,676
Ensembl chr 5:16,007,448...16,017,825
JBrowse link
G GPT glutamic--pyruvic transaminase treatment ISO protein:increased expression, activity:serum: RGD PMID:19085960 PMID:21772750 PMID:27293452 PMID:28487901 RGD:14975162 RGD:14975166 RGD:14975168 RGD:14975249 NCBI chr 4:297,747...302,498
Ensembl chr 4:297,748...320,056
JBrowse link
G GPT2 glutamic--pyruvic transaminase 2 ISO protein:increased expression, activity:serum: RGD PMID:19085960 RGD:14975249 NCBI chr 6:37,625,428...37,669,695
Ensembl chr 6:37,625,436...37,669,663
JBrowse link
G GRK4 G protein-coupled receptor kinase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 8:1,737,960...1,792,390
Ensembl chr 8:1,738,333...1,792,374
JBrowse link
G GSN gelsolin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 1:261,295,711...261,372,848
Ensembl chr 1:261,307,008...261,372,848
JBrowse link
G GSR glutathione-disulfide reductase treatment ISO mRNA, protein:increased expression:liver
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:23554813 PMID:24154663 PMID:25226513 PMID:28069987 RGD:10401878 RGD:7257532 NCBI chr15:54,382,564...54,433,989
Ensembl chr15:54,382,567...54,433,984
JBrowse link
G GSTA4 glutathione S-transferase alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:46,635,903...46,656,491
Ensembl chr 7:46,635,902...46,656,450
JBrowse link
G GSTM3 glutathione S-transferase mu 3 ISO CTD Direct Evidence: therapeutic CTD PMID:25743375 NCBI chr 4:110,330,027...110,332,957
Ensembl chr 4:110,330,028...110,332,962
JBrowse link
G GSTO1 glutathione S-transferase omega 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr14:115,206,434...115,216,624
Ensembl chr14:115,206,188...115,216,613
JBrowse link
G H2AX H2A.X variant histone treatment ISO RGD PMID:23265463 RGD:8693741 NCBI chr 9:46,308,824...46,310,494
Ensembl chr 9:46,309,653...46,310,084
JBrowse link
G HACL1 2-hydroxyacyl-CoA lyase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr13:2,786,007...2,840,882
Ensembl chr13:2,766,514...2,840,902
JBrowse link
G HADHA hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:112,753,343...112,797,627
Ensembl chr 3:112,752,865...112,797,733
JBrowse link
G HAMP hepcidin antimicrobial peptide ISO mRNA:increased expression:hepatocyte RGD PMID:24373749 RGD:11041724 NCBI chr 6:44,785,863...44,787,303
Ensembl chr 6:44,784,160...44,787,305
JBrowse link
G HAO2 hydroxyacid oxidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:101,588,510...101,787,818
Ensembl chr 4:101,588,861...101,732,304
JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr16:66,162,318...66,208,868 JBrowse link
G HMGB1 high mobility group box 1 treatment ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:19783637 PMID:29091898 RGD:15090820 NCBI chr11:7,195,556...7,321,071 JBrowse link
G HMOX1 heme oxygenase 1 treatment ISO CTD Direct Evidence: marker/mechanism|therapeutic RGD
CTD
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898 RGD:10762620 RGD:15090820
G HPD 4-hydroxyphenylpyruvate dioxygenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 PMID:22872058 NCBI chr14:30,845,608...30,857,658
Ensembl chr14:30,845,613...30,857,667
JBrowse link
G HPRT1 hypoxanthine phosphoribosyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:110,321,144...110,357,902
Ensembl chr  X:110,321,204...110,357,894
JBrowse link
G HPX hemopexin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 9:3,288,288...3,297,051
Ensembl chr 9:3,288,172...3,297,047
JBrowse link
G HRH2 histamine receptor H2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22926047 NCBI chr 2:81,883,670...81,932,464
Ensembl chr 2:81,883,673...81,932,275
JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:265,930,044...265,934,959
Ensembl chr 1:265,930,045...265,934,894
JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 ISO protein:altered localization:liver (rat) RGD PMID:12376827 RGD:10059389 NCBI chr 9:49,982,278...49,986,760
Ensembl chr 9:49,982,284...49,990,508
JBrowse link
G ICAM1 intercellular adhesion molecule 1 treatment ISO RGD PMID:29091898 RGD:15090820 NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
JBrowse link
G IDH2 isocitrate dehydrogenase (NADP(+)) 2 severity ISO RGD PMID:31121248 RGD:14985250 NCBI chr 7:55,654,298...55,675,571
Ensembl chr 7:55,651,609...55,675,554
JBrowse link
G IDO2 indoleamine 2,3-dioxygenase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32289347 NCBI chr17:9,277,039...9,344,405
Ensembl chr17:9,277,069...9,343,749
JBrowse link
G IFNG interferon gamma ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12153990 PMID:21245496 PMID:30013034 RGD:14975100 NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
JBrowse link
G IGF1 insulin like growth factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23639586 PMID:25226513 NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
JBrowse link
G IL11 interleukin 11 ISO CTD Direct Evidence: therapeutic CTD PMID:11421492 NCBI chr 6:59,540,482...59,544,909
Ensembl chr 6:59,541,213...59,544,896
JBrowse link
G IL12B interleukin 12B ISO CTD Direct Evidence: therapeutic CTD PMID:36520315 NCBI chr16:64,143,268...64,158,929
Ensembl chr16:64,143,268...64,158,929
JBrowse link
G IL17A interleukin 17A ISO CTD Direct Evidence: marker/mechanism CTD PMID:19633216 PMID:24949944 NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
JBrowse link
G IL18 interleukin 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19164858 NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
JBrowse link
G IL1A interleukin 1 alpha ISO CTD Direct Evidence: therapeutic CTD PMID:8218930 NCBI chr 3:43,718,320...43,731,668
Ensembl chr 3:43,718,368...43,731,119
JBrowse link
G IL1R2 interleukin 1 receptor type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 3:52,367,434...52,406,393
Ensembl chr 3:52,367,437...52,406,334
JBrowse link
G IL22 interleukin 22 ISO CTD Direct Evidence: therapeutic CTD PMID:15122762 PMID:16212920 PMID:23375450 NCBI chr 5:32,599,522...32,604,507
Ensembl chr 5:32,599,471...32,604,513
JBrowse link
G IL4 interleukin 4 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21094227 PMID:21735453 PMID:22107450 NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
JBrowse link
G IL6 interleukin 6 treatment ISO CTD Direct Evidence: therapeutic CTD
RGD
PMID:7532385 PMID:15763341 PMID:29091898 RGD:15090820 NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
JBrowse link
G IMMT inner membrane mitochondrial protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:58,575,175...58,632,337
Ensembl chr 3:58,575,175...58,633,742
JBrowse link
G IRAK1 interleukin 1 receptor associated kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:124,717,604...124,724,855
Ensembl chr  X:124,717,612...124,724,860
JBrowse link
G ITPR1 inositol 1,4,5-trisphosphate receptor type 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr13:61,068,131...61,398,918
Ensembl chr13:61,068,126...61,398,912
JBrowse link
G JUND JunD proto-oncogene, AP-1 transcription factor subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr 2:59,530,991...59,532,846 JBrowse link
G KEAP1 kelch like ECH associated protein 1 ISO RGD PMID:18417483 RGD:6893370 NCBI chr 2:69,280,940...69,290,267
Ensembl chr 2:69,276,336...69,294,382
JBrowse link
G KITLG KIT ligand ISO CTD Direct Evidence: therapeutic CTD PMID:12594235 NCBI chr 5:94,016,992...94,110,219
Ensembl chr 5:94,017,387...94,110,214
JBrowse link
G KNG1 kininogen 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20362651 PMID:30685357 NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,340...124,557,958
JBrowse link
G KRT18 keratin 18 ISO mRNA, protein:increased expression:liver (mouse)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:17340120 PMID:19783637 PMID:33483742 RGD:18337498 NCBI chr 5:18,217,686...18,221,432
Ensembl chr 5:18,217,691...18,221,429
JBrowse link
G KRT8 keratin 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:18,172,423...18,180,277
Ensembl chr 5:18,167,553...18,180,404
JBrowse link
G LAP3 leucine aminopeptidase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 8:12,590,335...12,619,102
Ensembl chr 8:12,590,330...12,619,107
JBrowse link
G LBP lipopolysaccharide binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr17:41,398,935...41,429,467
Ensembl chr17:41,393,818...41,429,551
JBrowse link
G LCAT lecithin-cholesterol acyltransferase ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr 6:28,550,356...28,553,561
Ensembl chr 6:28,550,358...28,553,566
JBrowse link
G LCN2 lipocalin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20362651 PMID:20623750 NCBI chr 1:268,609,975...268,614,651
Ensembl chr 1:268,609,887...268,614,644
JBrowse link
G LDLR low density lipoprotein receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:36108984 NCBI chr 2:69,828,348...69,864,823
Ensembl chr 2:69,828,332...69,864,827
JBrowse link
G LGALS3 galectin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22461450 NCBI chr 1:184,478,639...184,496,155
Ensembl chr 1:184,478,710...184,497,951
JBrowse link
G LIPC lipase C, hepatic type ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr 1:113,433,684...113,604,139
Ensembl chr 1:113,433,687...113,583,963
JBrowse link
G LOC100513779 solute carrier family 22 member 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:8,580,673...8,603,553 JBrowse link
G LOC100625684 olfactory receptor 51E2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 9:5,431,098...5,434,483
Ensembl chr 9:5,432,611...5,433,573
JBrowse link
G LOC100739508 glutathione S-transferase P-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 PMID:25226513 NCBI chr 2:5,005,498...5,009,247 JBrowse link
G LOC106510200 glutathione S-transferase Mu 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:110,378,016...110,413,483 JBrowse link
G LOC110258578 interleukin-1 beta-like treatment ISO CTD Direct Evidence: marker/mechanism|therapeutic RGD
CTD
PMID:19164858 PMID:23102243 PMID:28138970 PMID:29091898 PMID:29278859 More... RGD:13793380 RGD:14975281 RGD:15036799 RGD:15090820 RGD:7204421
G LOC110259958 hemoglobin subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:41,482,353...41,483,564 JBrowse link
G LPL lipoprotein lipase treatment ISO RGD PMID:27071702 RGD:13794380 NCBI chr14:4,104,761...4,134,964
Ensembl chr14:4,104,772...4,135,814
JBrowse link
G LRAT lecithin retinol acyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 8:74,412,226...74,428,713
Ensembl chr 8:74,409,461...74,419,681
JBrowse link
G LTB4R leukotriene B4 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28487374 NCBI chr 7:74,972,723...74,978,266
Ensembl chr 7:74,974,308...74,975,357
JBrowse link
G LTF lactotransferrin ISO CTD Direct Evidence: therapeutic CTD PMID:16141546 NCBI chr13:29,413,886...29,445,751
Ensembl chr13:29,413,886...29,445,739
JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 6:1,919,879...1,941,069
Ensembl chr 6:1,915,387...1,941,069
JBrowse link
G MAP3K5 mitogen-activated protein kinase kinase kinase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18700144 NCBI chr 1:27,380,143...27,600,500
Ensembl chr 1:27,380,142...27,600,493
JBrowse link
G MAT1A methionine adenosyltransferase 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr14:82,109,405...82,126,487
Ensembl chr14:82,107,390...82,127,049
JBrowse link
G MCCC1 methylcrotonyl-CoA carboxylase subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr13:120,983,226...121,070,695
Ensembl chr13:120,915,730...121,106,395
JBrowse link
G MDH1 malate dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 3:78,247,229...78,263,085
Ensembl chr 3:78,244,999...78,268,600
JBrowse link
G ME1 malic enzyme 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:82,799,878...82,989,895
Ensembl chr 1:82,799,684...82,991,085
JBrowse link
G MED1 mediator complex subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16109766 NCBI chr12:22,830,405...22,872,420
Ensembl chr12:22,841,205...22,872,409
JBrowse link
G MIR1 microRNA mir-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30125006 NCBI chr17:61,894,036...61,894,143
Ensembl chr17:61,894,036...61,894,143
JBrowse link
G MIR100 microRNA mir-100 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:49,157,909...49,157,988
Ensembl chr 9:49,157,909...49,157,988
JBrowse link
G MIR103-1 microRNA mir-103-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr16:55,329,442...55,329,523
Ensembl chr16:55,329,442...55,329,523
JBrowse link
G MIR107 microRNA mir-107 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr14:101,420,743...101,420,829
Ensembl chr14:101,420,743...101,420,829
JBrowse link
G MIR10A microRNA mir-10a ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr12:24,833,644...24,833,723
Ensembl chr12:24,833,627...24,833,730
JBrowse link
G MIR10B microRNA mir-10b ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr15:81,951,644...81,951,723
Ensembl chr15:81,951,636...81,951,736
JBrowse link
G MIR122 microRNA mir-122 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22045675 PMID:22363424 PMID:25359176 PMID:25527335 PMID:26489516 More... NCBI chr 1:162,329,776...162,329,860
Ensembl chr 1:162,329,767...162,329,860
JBrowse link
G MIR1249-1 microRNA mir-1249-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 5:4,187,912...4,187,993
Ensembl chr 5:4,187,912...4,187,993
JBrowse link
G MIR125B-1 microRNA mir-125b-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:49,109,435...49,109,514
Ensembl chr 9:49,109,435...49,109,514
JBrowse link
G MIR1306 microRNA mir-1306 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:51,473,918...51,473,997
Ensembl chr14:51,473,918...51,473,997
JBrowse link
G MIR1307 microRNA mir-1307 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:114,325,624...114,325,703
Ensembl chr14:114,325,625...114,325,704
JBrowse link
G MIR130A microRNA mir-130a ISO CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr 2:13,296,695...13,296,773
Ensembl chr 2:13,296,695...13,296,773
JBrowse link
G MIR132 microRNA mir-132 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr12:48,162,625...48,162,702
Ensembl chr12:48,162,614...48,162,714
JBrowse link
G MIR142 microRNA mir-142 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:34,609,378...34,609,457
Ensembl chr12:34,609,364...34,609,468
JBrowse link
G MIR143 microRNA mir-143 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30125006 NCBI chr 2:150,578,738...150,578,817
Ensembl chr 2:150,578,738...150,578,817
JBrowse link
G MIR148A microRNA mir-148a ISO CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr18:46,415,213...46,415,280
Ensembl chr18:46,415,202...46,415,281
JBrowse link
G MIR150-1 microRNA mir-150-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 6:54,580,912...54,580,988
Ensembl chr 6:54,580,912...54,580,988
JBrowse link
G MIR152 microRNA mir-152 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:24,292,249...24,292,328
Ensembl chr12:24,292,251...24,292,336
JBrowse link
G MIR155 microRNA mir-155 treatment ISO RGD PMID:26867493 PMID:27673475 PMID:29420849 RGD:21409750 RGD:25671463 RGD:25671474 NCBI chr13:189,138,822...189,138,902
Ensembl chr13:189,138,822...189,138,902
JBrowse link
G MIR17 microRNA mir-17 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:60,734,656...60,734,732
Ensembl chr11:60,734,656...60,734,732
JBrowse link
G MIR181C microRNA mir-181c ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 2:65,279,950...65,280,036
Ensembl chr 2:65,279,944...65,280,040
JBrowse link
G MIR18A microRNA mir-18a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:60,734,791...60,734,882
Ensembl chr11:60,734,791...60,734,882
JBrowse link
G MIR191 microRNA mir-191 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:31,655,484...31,655,563
Ensembl chr13:31,655,484...31,655,563
JBrowse link
G MIR192 microRNA mir-192 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22045675 PMID:25359176 PMID:28483554 PMID:28545106 NCBI chr 2:7,285,667...7,285,746
Ensembl chr 2:7,285,667...7,285,746
JBrowse link
G MIR193A microRNA mir-193a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:43,336,969...43,337,048
Ensembl chr12:43,336,969...43,337,048
JBrowse link
G MIR194B microRNA mir-194b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28844483 NCBI chr10:9,704,910...9,704,987
Ensembl chr10:9,704,910...9,704,987
JBrowse link
G MIR19A microRNA mir-19a ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr11:60,734,939...60,735,020
Ensembl chr11:60,734,939...60,735,020
JBrowse link
G MIR21 microRNA mir-21 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:36,065,267...36,065,358
Ensembl chr12:36,065,267...36,065,358
JBrowse link
G MIR217-1 microRNA mir-217-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 3:85,341,255...85,341,361
Ensembl chr 3:85,341,255...85,341,361
JBrowse link
G MIR218-1 microRNA mir-218-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:30125006 NCBI chr 8:15,047,602...15,047,685
Ensembl chr 8:15,047,602...15,047,685
JBrowse link
G MIR221 microRNA mir-221 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:40,571,068...40,571,137
Ensembl chr  X:40,571,068...40,571,137
JBrowse link
G MIR222 microRNA mir-222 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:40,571,808...40,571,887
Ensembl chr  X:40,571,808...40,571,887
JBrowse link
G MIR23A microRNA mir-23a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 2:65,308,117...65,308,186
Ensembl chr 2:65,308,117...65,308,186
JBrowse link
G MIR23B microRNA mir-23b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr10:27,080,197...27,080,276
Ensembl chr10:27,080,197...27,080,276
JBrowse link
G MIR27B microRNA mir-27b ISO CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr10:27,079,963...27,080,042
Ensembl chr10:27,079,954...27,080,056
JBrowse link
G MIR29B-2 microRNA mir-29b-2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 9:135,019,079...135,019,162
Ensembl chr 9:135,019,075...135,019,164
JBrowse link
G MIR29C microRNA mir-29c ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 PMID:30515189 NCBI chr 9:135,019,638...135,019,725
Ensembl chr 9:135,019,638...135,019,725
JBrowse link
G MIR30A microRNA mir-30a ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:25359176 PMID:28545106 NCBI chr 1:51,412,827...51,412,933
Ensembl chr 1:51,412,827...51,412,933
JBrowse link
G MIR30B microRNA mir-30b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 4:6,952,794...6,952,869
Ensembl chr 4:6,952,794...6,952,869
JBrowse link
G MIR30C-1 microRNA mir-30c-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 6:170,426,781...170,426,860
Ensembl chr 6:170,426,781...170,426,860
JBrowse link
G MIR335 microRNA mir-335 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr18:18,341,580...18,341,659
Ensembl chr18:18,341,568...18,341,659
JBrowse link
G MIR342 microRNA mir-342 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:121,021,761...121,021,840
Ensembl chr 7:121,021,761...121,021,840
JBrowse link
G MIR345-1 microRNA mir-345-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:121,193,720...121,193,799
Ensembl chr 7:121,193,716...121,193,799
JBrowse link
G MIR34C-1 microRNA mir-34c-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 9:39,280,278...39,280,357
Ensembl chr 9:39,280,278...39,280,357
JBrowse link
G MIR361 microRNA mir-361 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:68,924,500...68,924,579
Ensembl chr  X:68,924,500...68,924,579
JBrowse link
G MIR378-1 microRNA mir-378-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 2:150,825,865...150,825,944
Ensembl chr 2:150,825,865...150,825,944
JBrowse link
G MIR421 microRNA mir-421 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:59,550,992...59,551,069
Ensembl chr  X:59,550,987...59,551,071
JBrowse link
G MIR423 microRNA mir-423 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:46,211,525...46,211,604
Ensembl chr12:46,211,525...46,211,611
JBrowse link
G MIR452 microRNA mir-452 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:123,284,480...123,284,559
Ensembl chr  X:123,284,480...123,284,559
JBrowse link
G MIR455 microRNA mir-455 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 1:254,824,200...254,824,279
Ensembl chr 1:254,824,196...254,824,291
JBrowse link
G MIR497 microRNA mir-497 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:52,422,329...52,422,408
Ensembl chr12:52,422,330...52,422,411
JBrowse link
G MIR505 microRNA mir-505 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:114,563,942...114,564,021
Ensembl chr  X:114,563,942...114,564,021
JBrowse link
G MIR532 microRNA mir-532 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:43,705,258...43,705,337
Ensembl chr  X:43,705,258...43,705,337
JBrowse link
G MIR744 microRNA mir-744 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:28545106 NCBI chr12:56,464,848...56,464,927
Ensembl chr12:56,464,848...56,464,927
JBrowse link
G MIR885 microRNA mir-885 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:66,597,531...66,597,610
Ensembl chr13:66,597,531...66,597,610
JBrowse link
G MIR99A microRNA mir-99a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:181,302,483...181,302,562
Ensembl chr13:181,302,478...181,302,567
JBrowse link
G MIRLET7C microRNA let-7c ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:181,303,209...181,303,302
Ensembl chr13:181,303,209...181,303,302
JBrowse link
G MIRLET7D microRNA let-7d ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:43,468,501...43,468,596
Ensembl chr 3:43,468,501...43,468,596
JBrowse link
G MIRLET7G microRNA let-7g ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:34,406,140...34,406,219
Ensembl chr13:34,406,130...34,406,225
JBrowse link
G MIRLET7I microRNA let-7i ISO CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 5:27,252,802...27,252,886
Ensembl chr 5:27,252,787...27,252,894
JBrowse link
G MMP2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15763341 NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
JBrowse link
G MMP9 matrix metallopeptidase 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
JBrowse link
G MST1 macrophage stimulating 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr13:32,214,934...32,220,045
Ensembl chr13:32,214,937...32,219,902
JBrowse link
G MST1R macrophage stimulating 1 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:22575169 NCBI chr13:32,401,623...32,423,614
Ensembl chr13:32,409,555...32,421,920
JBrowse link
G MT-ND6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 ISO mRNA:decreased expression:blood RGD PMID:20130021 RGD:8657129 NCBI chr MT:14,739...15,266
Ensembl chr MT:14,739...15,266
JBrowse link
G MTHFR methylenetetrahydrofolate reductase treatment ISO CTD Direct Evidence: marker/mechanism
associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human)
CTD
RGD
PMID:18551038 PMID:19648163 PMID:30545275 RGD:14696733 NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
JBrowse link
G MTPN myotrophin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr18:13,330,049...13,395,297
Ensembl chr18:13,330,029...13,395,460
JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor ameliorates ISO RGD PMID:17615358 RGD:150521532 NCBI chr13:22,976,951...22,979,568
Ensembl chr13:22,966,137...22,983,109
JBrowse link
G NDUFS3 NADH:ubiquinone oxidoreductase core subunit S3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:15,031,147...15,036,880
Ensembl chr 2:15,031,149...15,036,880
JBrowse link
G NFATC4 nuclear factor of activated T cells 4 ISO CTD Direct Evidence: therapeutic CTD PMID:34192554 NCBI chr 7:74,918,982...74,929,688
Ensembl chr 7:74,918,984...74,929,600
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 treatment ISO CTD Direct Evidence: therapeutic
induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620)
CTD
RGD
PMID:18417483 PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 More... RGD:15090820 RGD:21201280 RGD:21201283 RGD:21201305 RGD:21201308 RGD:6893370 NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 treatment
susceptibility
ISO associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human) RGD PMID:29091898 PMID:31490979 RGD:15090820 RGD:40902984 NCBI chr 8:118,391,010...118,478,927
Ensembl chr 8:118,390,638...118,506,691
JBrowse link
G NFXL1 nuclear transcription factor, X-box binding like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 8:37,812,378...37,875,582
Ensembl chr 8:37,812,911...37,875,540
JBrowse link
G NME2 NME/NM23 nucleoside diphosphate kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:27,439,529...27,445,025
Ensembl chr12:27,439,260...27,445,027
JBrowse link
G NOTCH1 notch receptor 1 ISO CTD Direct Evidence: therapeutic CTD PMID:30394310
G NOX4 NADPH oxidase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 9:22,622,105...22,776,691
Ensembl chr 9:22,624,212...22,776,534
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 treatment ISO RGD PMID:28472605 PMID:28522909 PMID:29091898 RGD:13439737 RGD:13439739 RGD:15090820 NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 ISO CTD Direct Evidence: therapeutic CTD PMID:29943110 NCBI chr 6:84,225,670...84,228,156
Ensembl chr 6:84,225,694...84,228,481
JBrowse link
G NR1D1 nuclear receptor subfamily 1 group D member 1 treatment ISO RGD PMID:24497272 RGD:10448995 NCBI chr12:22,263,549...22,274,131
Ensembl chr12:22,263,657...22,271,643
JBrowse link
G NR1H3 nuclear receptor subfamily 1 group H member 3 ISO CTD Direct Evidence: therapeutic CTD PMID:17256725 NCBI chr 2:15,315,283...15,336,785
Ensembl chr 2:15,315,282...15,334,820
JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 treatment
severity
ISO mRNA:decreased expression:liver (rat)
CTD Direct Evidence: marker/mechanism
protein:decreased expression:liver (rat)
RGD
CTD
PMID:12875239 PMID:20573685 PMID:22711662 PMID:28827769 PMID:29091898 More... RGD:14701035 RGD:14701036 RGD:15042870 RGD:15045609 RGD:15090820 NCBI chr 5:83,607,222...83,732,668
Ensembl chr 5:83,604,294...83,684,604
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 susceptibility ISO CTD Direct Evidence: marker/mechanism|therapeutic
associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human)
CTD
RGD
PMID:19797606 PMID:28058446 PMID:31490979 RGD:40902984 NCBI chr13:140,373,571...140,406,129
Ensembl chr13:140,364,075...140,406,112
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:14742670 PMID:25656644 PMID:28058446 NCBI chr 4:89,226,314...89,231,781
Ensembl chr 4:89,226,690...89,236,431
JBrowse link
G NR2F2 nuclear receptor subfamily 2 group F member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:83,076,119...83,090,250
Ensembl chr 7:83,076,124...83,090,535
JBrowse link
G NR5A2 nuclear receptor subfamily 5 group A member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29515023 NCBI chr10:22,727,865...22,866,905
Ensembl chr10:22,715,735...22,865,364
JBrowse link
G NREP neuronal regeneration related protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:117,505,851...117,867,805
Ensembl chr 2:117,838,660...117,867,801
JBrowse link
G NTN1 netrin 1 ISO CTD Direct Evidence: therapeutic CTD PMID:35292334 NCBI chr12:54,089,444...54,292,191
Ensembl chr12:54,089,472...54,292,193
JBrowse link
G NUS1 NUS1 dehydrodolichyl diphosphate synthase subunit ISO CTD Direct Evidence: therapeutic CTD PMID:33812996 NCBI chr 1:44,156,771...44,186,224
Ensembl chr 1:44,156,778...44,186,194
JBrowse link
G OCIAD1 OCIA domain containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 8:38,745,415...38,769,255
Ensembl chr 8:38,745,338...38,769,253
JBrowse link
G OGDH oxoglutarate dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr18:50,609,415...50,684,990
Ensembl chr18:50,609,418...50,684,964
JBrowse link
G P4HB prolyl 4-hydroxylase subunit beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:1,121,816...1,131,291
Ensembl chr12:1,121,824...1,131,289
JBrowse link
G PAH phenylalanine hydroxylase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:81,385,401...81,460,569
Ensembl chr 5:81,385,435...81,463,451
JBrowse link
G PAN2 poly(A) specific ribonuclease subunit PAN2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 5:21,712,222...21,730,528
Ensembl chr 5:21,712,261...21,727,903
JBrowse link
G PANX1 pannexin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29246445 NCBI chr 9:26,443,425...26,491,010
Ensembl chr 9:26,443,815...26,491,002
JBrowse link
G PARK7 Parkinsonism associated deglycase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:68,629,327...68,645,147
Ensembl chr 6:68,629,214...68,645,516
JBrowse link
G PC pyruvate carboxylase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:5,566,608...5,587,797
Ensembl chr 2:5,518,517...5,587,797
JBrowse link
G PCOLCE procollagen C-endopeptidase enhancer ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:8,523,455...8,528,749
Ensembl chr 3:8,523,449...8,528,739
JBrowse link
G PCYT1A phosphate cytidylyltransferase 1A, choline ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr13:133,794,337...133,851,004
Ensembl chr13:133,818,761...133,850,996
JBrowse link
G PDK4 pyruvate dehydrogenase kinase 4 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21182459 PMID:31809757 NCBI chr 9:75,246,956...75,260,134
Ensembl chr 9:75,246,002...75,260,134
JBrowse link
G PDLIM5 PDZ and LIM domain 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 8:125,044,027...125,259,969
Ensembl chr 8:125,044,028...125,259,945
JBrowse link
G PEX11A peroxisomal biogenesis factor 11 alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:55,256,239...55,264,253
Ensembl chr 7:55,256,220...55,264,247
JBrowse link
G PGM1 phosphoglucomutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:148,851,183...148,918,891
Ensembl chr 6:148,851,183...148,994,952
JBrowse link
G PLAT plasminogen activator, tissue type ISO CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr17:11,195,599...11,223,821
Ensembl chr17:11,195,602...11,224,032
JBrowse link
G PLG plasminogen ISO CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr 1:7,062,399...7,109,521
Ensembl chr 1:7,061,192...7,110,555
JBrowse link
G PLS3 plastin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:94,885,098...94,971,664
Ensembl chr  X:94,885,118...94,971,659
JBrowse link
G PNP purine nucleoside phosphorylase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 7:78,426,838...78,447,029
Ensembl chr 7:78,424,740...78,447,012
JBrowse link
G PNRC1 proline rich nuclear receptor coactivator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:57,128,100...57,132,071
Ensembl chr 1:57,128,303...57,136,135
JBrowse link
G POLG DNA polymerase gamma, catalytic subunit susceptibility
no_association
ISO DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human)
CTD Direct Evidence: marker/mechanism
DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human)
RGD
CTD
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931 RGD:15039297 RGD:15039302 NCBI chr 7:54,889,150...54,907,167
Ensembl chr 7:54,889,157...54,906,844
JBrowse link
G POLR2G RNA polymerase II subunit G ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:9,004,388...9,008,631
Ensembl chr 2:9,004,390...9,017,779
JBrowse link
G PON1 paraoxonase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 9:74,943,646...74,974,720
Ensembl chr 9:74,926,048...74,974,723
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha ISO CTD Direct Evidence: marker/mechanism
LPS-induced acute liver damage
CTD
RGD
PMID:21262334 PMID:24385052 RGD:5509941 NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma ISO mRNA, protein:decreased expression:liver RGD PMID:26599535 RGD:11554658 NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944
JBrowse link
G PPP1R16A protein phosphatase 1 regulatory subunit 16A ISO CTD Direct Evidence: marker/mechanism CTD PMID:145039 PMID:19481104 NCBI chr 4:302,621...320,048
Ensembl chr 4:297,748...320,056
JBrowse link
G PPTC7 protein phosphatase targeting COQ7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:31,905,379...31,946,555
Ensembl chr14:31,906,262...31,946,554
JBrowse link
G PRKAA1 protein kinase AMP-activated catalytic subunit alpha 1 treatment ISO RGD PMID:29091898 RGD:15090820 NCBI chr16:25,745,902...25,783,524
Ensembl chr16:25,745,324...25,783,707
JBrowse link
G PRKCD protein kinase C delta ISO CTD Direct Evidence: therapeutic CTD PMID:30393195 NCBI chr13:35,290,835...35,323,245
Ensembl chr13:35,290,610...35,323,356
JBrowse link
G PRKDC protein kinase, DNA-activated, catalytic subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:21224054 NCBI chr 4:79,687,375...79,850,146
Ensembl chr 4:79,687,375...79,846,656
JBrowse link
G PTF1A pancreas associated transcription factor 1a ISO CTD Direct Evidence: therapeutic CTD PMID:21182459 NCBI chr10:51,817,697...51,820,147
Ensembl chr10:51,817,924...51,819,960
JBrowse link
G PTGES2 prostaglandin E synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31444509 NCBI chr 1:268,585,725...268,591,356
Ensembl chr 1:268,583,439...268,590,855
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 treatment ISO CTD Direct Evidence: therapeutic CTD
RGD
PMID:11743745 PMID:29091898 RGD:15090820 NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
JBrowse link
G PUM1 pumilio RNA binding family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:87,546,388...87,687,483
Ensembl chr 6:87,547,320...87,687,442
JBrowse link
G PYGL glycogen phosphorylase L ISO protein:increased expression:serum (rat)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:25231249 PMID:25336395 RGD:21079733 NCBI chr 1:180,645,849...180,704,124
Ensembl chr 1:180,620,314...180,719,979
JBrowse link
G RASA1 RAS p21 protein activator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:94,879,615...94,992,725
Ensembl chr 2:94,878,911...94,993,450
JBrowse link
G RBP1 retinol binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr13:80,380,958...80,407,328
Ensembl chr13:80,380,962...80,407,458
JBrowse link
G RDH13 retinol dehydrogenase 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27865848 NCBI chr 6:59,274,383...59,293,139
Ensembl chr 6:59,274,387...59,292,765
JBrowse link
G REEP5 receptor accessory protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 2:116,845,681...116,886,361
Ensembl chr 2:116,845,571...116,886,358
JBrowse link
G RGN regucalcin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr  X:41,725,660...41,749,736
Ensembl chr  X:41,726,526...41,749,381
JBrowse link
G RIPK3 receptor interacting serine/threonine kinase 3 ISO CTD Direct Evidence: therapeutic
protein:increased expression:liver (mouse)
CTD
RGD
PMID:26769846 PMID:28205631 RGD:127229945 NCBI chr 7:74,951,145...74,955,255
Ensembl chr 7:74,951,145...74,955,251
JBrowse link
G S100A11 S100 calcium binding protein A11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:97,233,833...97,239,081
Ensembl chr 4:97,233,811...97,243,423
JBrowse link
G SCARB1 scavenger receptor class B member 1 ISO mRNA:increased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr14:28,301,421...28,393,568
Ensembl chr14:28,301,294...28,393,568
JBrowse link
G SELENBP1 selenium binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 4:97,860,925...97,894,007
Ensembl chr 4:97,837,981...97,894,301
JBrowse link
G SEMA3A semaphorin 3A ISO CTD Direct Evidence: therapeutic CTD PMID:33290778 NCBI chr 9:95,934,937...96,387,950
Ensembl chr 9:96,181,770...96,387,950
JBrowse link
G SEMA4A semaphorin 4A ISO CTD Direct Evidence: marker/mechanism CTD PMID:33290778 NCBI chr 4:93,865,054...93,892,995
Ensembl chr 4:93,865,057...93,886,371
JBrowse link
G SENP2 SUMO specific peptidase 2 ISO CTD Direct Evidence: therapeutic CTD PMID:29535048 NCBI chr13:123,429,915...123,469,913
Ensembl chr13:123,429,995...123,471,926
JBrowse link
G SERPINA1 serpin family A member 1 susceptibility ISO protein:decreased expression:plasma
DNA:missense mutation:cds:p.E264V(human)
RGD PMID:11140575 PMID:20170533 RGD:14695048 RGD:1643168 NCBI chr 7:115,604,282...115,616,915
Ensembl chr 7:115,583,043...115,614,645
JBrowse link
G SERPINA6 serpin family A member 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:115,535,552...115,554,536
Ensembl chr 7:115,535,697...115,554,570
JBrowse link
G SERPINE1 serpin family E member 1 treatment ISO associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human) RGD PMID:23183238 RGD:14696750 NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
JBrowse link
G SERPING1 serpin family G member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:13,324,160...13,338,826
Ensembl chr 2:13,324,158...13,338,663
JBrowse link
G SESN2 sestrin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:28209544 NCBI chr 6:85,321,982...85,348,044
Ensembl chr 6:85,324,228...85,348,032
JBrowse link
G SGF29 SAGA complex associated factor 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:18,354,798...18,387,930
Ensembl chr 3:18,354,799...18,387,856
JBrowse link
G SHC1 SHC adaptor protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 PMID:32659284 NCBI chr 4:94,818,226...94,831,766
Ensembl chr 4:94,810,875...94,831,765
JBrowse link
G SLC10A1 solute carrier family 10 member 1 ISO mRNA:decreased expression:liver (rat) RGD PMID:28827769 RGD:15045609 NCBI chr 7:93,400,037...93,421,989
Ensembl chr 7:93,397,608...93,421,985
JBrowse link
G SLC10A7 solute carrier family 10 member 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 8:82,115,057...82,355,660
Ensembl chr 8:82,115,056...82,355,655
JBrowse link
G SLC13A4 solute carrier family 13 member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr18:13,593,735...13,641,649
Ensembl chr18:13,593,756...13,636,180
JBrowse link
G SLC22A8 solute carrier family 22 member 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:8,782,030...8,800,998
Ensembl chr 2:8,782,060...8,800,997
JBrowse link
G SLC25A29 solute carrier family 25 member 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:121,178,211...121,192,369
Ensembl chr 7:121,178,161...121,192,278
JBrowse link
G SLC7A5 solute carrier family 7 member 5 treatment ISO RGD PMID:9200186 RGD:151357001 NCBI chr 6:1,545,940...1,574,298
Ensembl chr 6:1,545,944...1,574,285
JBrowse link
G SLPI secretory leukocyte peptidase inhibitor ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr17:47,595,804...47,598,364
Ensembl chr17:47,595,803...47,598,387
JBrowse link
G SNX18 sorting nexin 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr16:33,776,964...33,801,391
Ensembl chr16:33,776,746...33,847,624
JBrowse link
G SOD1 superoxide dismutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 PMID:27349771 NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
JBrowse link
G SOD2 superoxide dismutase 2 susceptibility
severity
treatment
ISO CTD Direct Evidence: marker/mechanism
DNA:SNP:cds:p.Val16Ala(human)
associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human)
RGD
CTD
PMID:19332662 PMID:19647030 PMID:20578157 PMID:25226513 PMID:27019981 RGD:11060605 RGD:26923957 RGD:26923959 RGD:26923961 NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
JBrowse link
G SOD3 superoxide dismutase 3 ISO CTD Direct Evidence: therapeutic CTD PMID:11529661 NCBI chr 8:18,796,633...18,802,156
Ensembl chr 8:18,796,637...18,802,152
JBrowse link
G SORD sorbitol dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12763371 NCBI chr 1:126,659,198...126,701,084
Ensembl chr 1:126,655,156...126,701,138
JBrowse link
G SORL1 sortilin related receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 9:48,435,350...48,653,670
Ensembl chr 9:48,435,345...48,653,655
JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
JBrowse link
G SRP72 signal recognition particle 72 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 8:55,729,202...55,762,298
Ensembl chr 8:55,729,116...55,762,015
JBrowse link
G STAT4 signal transducer and activator of transcription 4 severity ISO protein:increased phosphorylation:liver, inflammatory cell (mouse)
mRNA:increased expression:liver, macrophage (mouse)
RGD PMID:23876342 PMID:24731448 RGD:25671417 RGD:25671422 NCBI chr15:95,656,206...95,764,099
Ensembl chr15:95,656,077...95,763,472
JBrowse link
G STING1 stimulator of interferon response cGAMP interactor 1 ISO CTD Direct Evidence: therapeutic CTD PMID:36520315 NCBI chr 2:141,359,402...141,367,222
Ensembl chr 2:141,358,993...141,367,198
JBrowse link
G SULT1C3 sulfotransferase family 1C member 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:47,838,671...47,864,646
Ensembl chr 3:47,838,558...47,856,943
JBrowse link
G SULT1E1 sulfotransferase family 1E, estrogen-preferring, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 8:66,811,536...66,838,181
Ensembl chr 8:66,811,550...66,834,473
JBrowse link
G SULT2B1 sulfotransferase family 2B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27052460 NCBI chr 6:53,928,248...53,963,443
Ensembl chr 6:53,928,248...53,963,443
JBrowse link
G SUOX sulfite oxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:21,395,246...21,399,715
Ensembl chr 5:21,395,262...21,399,710
JBrowse link
G TAGLN2 transgelin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:90,566,272...90,574,762 JBrowse link
G TALDO1 transaldolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19436114 NCBI chr 2:464,781...472,836
Ensembl chr 2:464,728...472,835
JBrowse link
G TBXA2R thromboxane A2 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:22206755 NCBI chr 2:75,068,413...75,081,305
Ensembl chr 2:75,068,698...75,087,731
JBrowse link
G TCTN1 tectonic family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr14:31,953,996...32,010,202
Ensembl chr14:31,954,000...32,010,185
JBrowse link
G TF transferrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr13:74,930,655...74,970,599
Ensembl chr13:74,930,655...74,972,763
JBrowse link
G TGFB1 transforming growth factor beta 1 treatment ISO RGD PMID:27516150 RGD:14995464 NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28560358 NCBI chr 1:240,842,735...240,918,267
Ensembl chr 1:240,860,156...240,918,528
JBrowse link
G THBS1 thrombospondin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35357534 NCBI chr 1:131,728,781...131,746,098
Ensembl chr 1:131,728,784...131,746,115
JBrowse link
G THPO thrombopoietin ISO CTD Direct Evidence: therapeutic CTD PMID:33122006 NCBI chr13:122,259,654...122,267,860
Ensembl chr13:122,260,215...122,267,860
JBrowse link
G TLR4 toll like receptor 4 disease_progression ISO RGD PMID:17504260 RGD:14697733 NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
JBrowse link
G TLR5 toll like receptor 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30508503 NCBI chr10:19,387,666...19,410,024
Ensembl chr10:19,387,666...19,410,024
JBrowse link
G TLR9 toll like receptor 9 treatment
severity
ISO protein:increased expression: blood, neutrophil (human) RGD PMID:19164858 PMID:23509352 PMID:26457748 RGD:18337465 RGD:18337473 RGD:18337476 NCBI chr13:34,353,444...34,370,990
Ensembl chr13:34,349,609...34,357,673
JBrowse link
G TMED7 transmembrane p24 trafficking protein 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 2:119,794,608...119,804,406
Ensembl chr 2:119,788,483...119,804,463
JBrowse link
G TMEM117 transmembrane protein 117 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 5:74,917,081...75,402,839
Ensembl chr 5:74,917,463...75,406,367
JBrowse link
G TMEM164 transmembrane protein 164 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr  X:90,105,293...90,289,674
Ensembl chr  X:90,106,036...90,289,669
JBrowse link
G TMEM38B transmembrane protein 38B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:246,973,447...247,024,019
Ensembl chr 1:246,973,436...247,027,527
JBrowse link
G TNF tumor necrosis factor treatment
severity
ISO CTD Direct Evidence: marker/mechanism|therapeutic
protein:increased expression:serum (rat)
RGD
CTD
PMID:7532385 PMID:9309314 PMID:9696492 PMID:10801287 PMID:10801288 More... RGD:10450531 RGD:14696804 RGD:14975281 RGD:14995429 RGD:14995432 RGD:14995435 RGD:14995437 RGD:14995485 RGD:15036799 RGD:15090820 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
JBrowse link
G TRPM2 transient receptor potential cation channel subfamily M member 2 ISO RGD PMID:24569808 RGD:9999438 NCBI chr13:207,212,339...207,263,313
Ensembl chr13:207,212,457...207,262,064
JBrowse link
G TTR transthyretin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,326...115,503,977
JBrowse link
G TUBA1A tubulin alpha 1a ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:15,186,059...15,190,211
Ensembl chr 5:15,185,532...15,190,428
JBrowse link
G TUBB4B tubulin beta 4B class IVb ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249
G UBA5 ubiquitin like modifier activating enzyme 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr13:73,831,485...73,859,781
Ensembl chr13:73,822,920...73,868,423
JBrowse link
G UNC93B1 unc-93 homolog B1, TLR signaling regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:4,898,414...4,909,833
Ensembl chr 2:4,898,409...4,909,856
JBrowse link
G USP5 ubiquitin specific peptidase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:63,843,742...63,858,835
Ensembl chr 5:63,843,745...63,858,716
JBrowse link
G VEGFA vascular endothelial growth factor A treatment ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:17784864 PMID:25231249 RGD:15003197 NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
JBrowse link
G VIM vimentin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr10:43,516,441...43,526,172
Ensembl chr10:43,517,307...43,526,170
JBrowse link
G VWF von Willebrand factor ISO protein:increased expression:liver:
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:7531171 PMID:28527913 RGD:11079232 NCBI chr 5:64,516,627...64,655,938
Ensembl chr 5:64,519,186...65,002,452
JBrowse link
G WASL WASP like actin nucleation promoting factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr18:23,722,188...23,789,516
Ensembl chr18:23,722,188...23,789,506
JBrowse link
G XRCC1 X-ray repair cross complementing 1 susceptibility ISO DNA:haploinsufficiency: : (mouse) RGD PMID:21737425 RGD:15036796 NCBI chr 6:50,403,691...50,425,730
Ensembl chr 6:50,403,689...50,425,729
JBrowse link
G XYLB xylulokinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr13:23,173,855...23,225,583
Ensembl chr13:23,173,939...23,225,951
JBrowse link
G ZDHHC23 zinc finger DHHC-type palmitoyltransferase 23 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr13:145,981,955...145,997,599
Ensembl chr13:145,970,851...145,997,044
JBrowse link
drug allergy term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC2 ATP binding cassette subfamily C member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20216337 NCBI chr14:110,955,698...111,038,898
Ensembl chr14:110,955,633...111,037,537
JBrowse link
G ACE angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18727619 NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
JBrowse link
G ADORA1 adenosine A1 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:19019667 NCBI chr 9:113,835,279...113,875,899
Ensembl chr 9:113,835,921...113,872,365
JBrowse link
G ADORA2A adenosine A2a receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:19019667 NCBI chr14:49,467,186...49,485,845
Ensembl chr14:49,468,877...49,485,850
JBrowse link
G CCL11 chemokine (C-C motif) ligand 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14616128 NCBI chr12:40,779,906...40,782,862
Ensembl chr12:40,779,173...40,782,893
JBrowse link
G CCL24 C-C motif chemokine ligand 24 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14616128 NCBI chr 3:10,347,397...10,361,500 JBrowse link
G CYSLTR1 cysteinyl leukotriene receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16630147 NCBI chr  X:62,380,778...62,407,736
Ensembl chr  X:62,380,780...62,456,689
JBrowse link
G CYSLTR2 cysteinyl leukotriene receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15970796 NCBI chr11:18,988,665...19,011,015
Ensembl chr11:18,987,174...19,011,015
JBrowse link
G FASLG Fas ligand ISO CTD Direct Evidence: marker/mechanism CTD PMID:19706026 NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
JBrowse link
G FCER1A Fc epsilon receptor Ia ISO CTD Direct Evidence: marker/mechanism CTD PMID:17125826 PMID:20485159 NCBI chr 4:91,118,867...91,125,448
Ensembl chr 4:91,118,879...91,125,437
JBrowse link
G FCER1G Fc epsilon receptor Ig ISO CTD Direct Evidence: marker/mechanism CTD PMID:18534082 PMID:18595682 NCBI chr 4:89,242,467...89,246,344
Ensembl chr 4:89,242,472...89,246,450
JBrowse link
G GZMB granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) ISO CTD Direct Evidence: marker/mechanism CTD PMID:19706026 NCBI chr 7:74,705,499...74,708,781
Ensembl chr 7:74,705,409...74,708,790
JBrowse link
G HNMT histamine N-methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr15:13,733,412...13,768,106
Ensembl chr15:13,732,680...13,768,199
JBrowse link
G HSPA1L heat shock protein family A (Hsp70) member 1 like ISO CTD Direct Evidence: marker/mechanism CTD PMID:16538175 NCBI chr 7:23,909,960...23,938,678
Ensembl chr 7:23,909,960...23,914,629
JBrowse link
G IL10 interleukin 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19222424 PMID:20485159 NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
JBrowse link
G IL13 interleukin 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
JBrowse link
G IL2 interleukin 2 ISO RGD PMID:1549655 RGD:8662975 NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
JBrowse link
G IL4 interleukin 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15867870 PMID:20485159 NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
JBrowse link
G IL4R interleukin 4 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 3:19,526,343...19,576,792
Ensembl chr 3:19,523,564...19,576,544
JBrowse link
G LOC100737977 tumor necrosis factor receptor superfamily member 10B-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:19652058 NCBI chr14:7,344,788...7,371,086 JBrowse link
G LOC100739508 glutathione S-transferase P-like susceptibility ISO associated with Acquired Immunodeficiency Syndrome;DNA:polymorphism:exon:A>G313 (rs1695) (human)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:16297214 PMID:20485159 RGD:5490995 NCBI chr 2:5,005,498...5,009,247 JBrowse link
G LTC4S leukotriene C4 synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16433794 NCBI chr 2:78,799,446...78,802,281
Ensembl chr 2:78,799,449...78,802,285
JBrowse link
G MLN motilin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16538176 NCBI chr 7:30,003,501...30,013,064
Ensembl chr 7:30,003,526...30,013,064
JBrowse link
G MS4A2 membrane spanning 4-domains A2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16839402 PMID:18534082 PMID:20485159 NCBI chr 2:11,400,415...11,420,314
Ensembl chr 2:11,400,420...11,420,298
JBrowse link
G NLRP3 NLR family pyrin domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19767079 NCBI chr 2:56,892,241...56,977,412
Ensembl chr 2:56,892,243...56,977,228
JBrowse link
G POSTN periostin ISO CTD Direct Evidence: marker/mechanism CTD PMID:18391768 NCBI chr11:13,225,183...13,258,973
Ensembl chr11:13,224,959...13,258,978
JBrowse link
G PTGER3 prostaglandin E receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20587336 NCBI chr 6:141,958,955...142,160,437
Ensembl chr 6:141,958,955...142,161,286
JBrowse link
G PTGS1 prostaglandin-endoperoxide synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17508966 NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
JBrowse link
G TAC1 tachykinin precursor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21233199 NCBI chr 9:77,197,403...77,206,529
Ensembl chr 9:77,197,536...77,206,523
JBrowse link
G TBXAS1 thromboxane A synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21449675 NCBI chr18:9,717,291...9,886,699
Ensembl chr18:9,717,294...9,886,681
JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:11294926 PMID:20485159 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
JBrowse link
Drug Eruptions term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX5 arachidonate 5-lipoxygenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr14:90,859,209...90,907,084
Ensembl chr14:90,859,016...90,907,094
JBrowse link
G APOA1 apolipoprotein A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 9:44,216,481...44,218,360
Ensembl chr 9:44,216,392...44,218,713
JBrowse link
G APOC2 apolipoprotein C2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 6:51,404,219...51,406,302 JBrowse link
G APOC3 apolipoprotein C3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 9:44,211,171...44,213,538
Ensembl chr 9:44,211,194...44,213,533
JBrowse link
G BDNF brain derived neurotrophic factor ISO mRNA:increased expression:lymph node, ear: RGD PMID:19904815 RGD:8657071 NCBI chr 2:32,623,668...32,679,293
Ensembl chr 2:32,624,048...32,679,765
JBrowse link
G C4A complement C4A (Rodgers blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 7:24,068,019...24,083,060
Ensembl chr 7:24,068,019...24,083,061
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
JBrowse link
G CYP2C49 cytochrome P450 2C49 susceptibility
treatment
ISO DNA:SNP: :Rs4244285(human)
associated with tuberculosis; DNA.polymorphism, haplotype:cds:p.W212X (human)
RGD PMID:20941486 PMID:23551241 RGD:11352742 RGD:124713543 NCBI chr14:106,571,803...106,612,082
Ensembl chr14:106,285,173...106,612,455
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
JBrowse link
G FCER1A Fc epsilon receptor Ia ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr 4:91,118,867...91,125,448
Ensembl chr 4:91,118,879...91,125,437
JBrowse link
G IFNG interferon gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
JBrowse link
G IL17A interleukin 17A ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
JBrowse link
G IL18 interleukin 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18204966 NCBI chr 9:39,839,959...39,861,258
Ensembl chr 9:39,834,973...39,861,219
JBrowse link
G IL2 interleukin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr 8:101,640,938...101,645,683
Ensembl chr 8:101,640,944...101,645,609
JBrowse link
G IL4 interleukin 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
JBrowse link
G KNG1 kininogen 1 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:1371395 PMID:3034372 NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,340...124,557,958
JBrowse link
G MPO myeloperoxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:18204966 NCBI chr12:34,557,031...34,570,091
Ensembl chr12:34,556,408...34,567,904
JBrowse link
G MTHFR methylenetetrahydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:14723717 NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
JBrowse link
G TAC1 tachykinin precursor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:1371395 NCBI chr 9:77,197,403...77,206,529
Ensembl chr 9:77,197,536...77,206,523
JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
JBrowse link
G TTR transthyretin ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,326...115,503,977
JBrowse link
Drug Hypersensitivity Syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G C1QA complement C1q A chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 6:80,586,259...80,589,213
Ensembl chr 6:80,586,280...80,589,204
JBrowse link
G C1QB complement C1q B chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 6:80,601,680...80,606,076
Ensembl chr 6:80,601,665...80,607,471
JBrowse link
G C1QC complement C1q C chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 6:80,592,591...80,597,464
Ensembl chr 6:80,592,473...80,597,452
JBrowse link
G CRP C-reactive protein, pentraxin-related ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 4:90,793,361...90,801,020
Ensembl chr 4:90,793,350...90,805,218
JBrowse link
G HSPA1L heat shock protein family A (Hsp70) member 1 like ISO DNA:polymorphism, haplotype: :p.M493T (human) RGD PMID:15024131 RGD:8662461 NCBI chr 7:23,909,960...23,938,678
Ensembl chr 7:23,909,960...23,914,629
JBrowse link
G IL1RN interleukin 1 receptor antagonist ISO DNA:SNP:intron:rs2234663 (human) RGD PMID:23461376 RGD:11051970
G LBP lipopolysaccharide binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr17:41,398,935...41,429,467
Ensembl chr17:41,393,818...41,429,551
JBrowse link
G LOC110258578 interleukin-1 beta-like ISO DNA:SNP:promoter:-511C>T (rs 16944) (human) RGD PMID:23461376 RGD:11051970
G LRG1 leucine rich alpha-2-glycoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 2:74,300,598...74,303,117
Ensembl chr 2:74,300,619...74,314,315
JBrowse link
G ORM1 orosomucoid 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 1:254,939,154...254,943,065 JBrowse link
G VWF von Willebrand factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 5:64,516,627...64,655,938
Ensembl chr 5:64,519,186...65,002,452
JBrowse link
Drug-Induced Dyskinesia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABAT 4-aminobutyrate aminotransferase ISO RGD PMID:6445277 PMID:7740056 RGD:10047091 RGD:1598524 NCBI chr 3:33,913,068...33,960,804
Ensembl chr 3:33,908,970...34,015,474
JBrowse link
G CACNA1D calcium voltage-gated channel subunit alpha1 D ISO RGD PMID:18947822 RGD:6906919 NCBI chr13:35,568,534...35,911,483
Ensembl chr13:35,436,519...35,909,662
JBrowse link
G CAT catalase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19109989 NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
JBrowse link
G CCK cholecystokinin ISO CTD Direct Evidence: therapeutic CTD PMID:2320253 NCBI chr13:25,940,674...25,945,879
Ensembl chr13:25,937,645...25,945,793
JBrowse link
G COMT catechol-O-methyltransferase ISO RGD PMID:16437585 RGD:2289781 NCBI chr14:51,384,729...51,403,997
Ensembl chr14:51,385,738...51,403,998
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 ISO RGD PMID:12629505 RGD:1358549 NCBI chr 5:6,539,021...6,543,643
Ensembl chr 5:6,538,907...6,543,642
JBrowse link
G DBN1 drebrin 1 ISO levodopainduced; protein:increased expression:striatum: RGD PMID:23241013 RGD:10398811 NCBI chr 2:80,480,603...80,495,797
Ensembl chr 2:80,479,460...80,495,796
JBrowse link
G DDC dopa decarboxylase ISO associated with Parkinson Disease; protein:decreased expression:striatum (rat) RGD PMID:20232137 RGD:5128860 NCBI chr 9:136,496,364...136,571,220
Ensembl chr 9:136,496,365...136,571,212
JBrowse link
G DRD1 dopamine receptor D1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:7845605 PMID:10858612 PMID:16982285 PMID:19520364 NCBI chr16:49,189,555...49,193,722
Ensembl chr16:49,189,602...49,191,976
JBrowse link
G DRD2 dopamine receptor D2 ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:7845605 PMID:10534246 PMID:14629710 PMID:18707801 RGD:2311579 NCBI chr 9:41,068,618...41,135,262
Ensembl chr 9:41,068,779...41,133,599
JBrowse link
G DRD3 dopamine receptor D3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20945430 NCBI chr13:145,769,294...145,817,997
Ensembl chr13:145,771,774...145,819,168
JBrowse link
G EGR1 early growth response 1 ISO RGD PMID:22153973 RGD:10395307 NCBI chr 2:140,440,829...140,445,302
Ensembl chr 2:140,441,421...140,445,296
JBrowse link
G FOSB FosB proto-oncogene, AP-1 transcription factor subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:17219962 NCBI chr 6:51,836,780...51,844,531
Ensembl chr 6:51,837,719...51,844,529
JBrowse link
G GAD1 glutamate decarboxylase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:9767399 NCBI chr15:76,991,863...77,034,819
Ensembl chr15:76,991,928...77,034,812
JBrowse link
G GCH1 GTP cyclohydrolase 1 ISO CTD Direct Evidence: therapeutic CTD PMID:15659429 NCBI chr 1:184,201,232...184,264,060
Ensembl chr 1:184,199,679...184,257,315
JBrowse link
G GDNF glial cell derived neurotrophic factor ISO CTD Direct Evidence: therapeutic CTD PMID:11168568 NCBI chr16:22,936,602...22,965,929
Ensembl chr16:22,936,604...22,966,536
JBrowse link
G GLUL glutamate-ammonia ligase ISO RGD PMID:6445277 RGD:10047091 NCBI chr 9:123,751,551...123,762,575
Ensembl chr 9:123,751,548...123,762,547
JBrowse link
G GRK6 G protein-coupled receptor kinase 6 ISO associated with Parkinson Disease RGD PMID:20410529 RGD:5684919 NCBI chr 2:80,496,105...80,527,208
Ensembl chr 2:80,508,979...80,527,210
JBrowse link
G GSK3B glycogen synthase kinase 3 beta treatment ISO associated with Parkinsonian Disorders RGD PMID:26997328 RGD:13792768 NCBI chr13:140,136,109...140,370,197
Ensembl chr13:140,136,158...140,369,569
JBrowse link
G HOMER1 homer scaffold protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24126708 NCBI chr 2:88,116,664...88,253,843
Ensembl chr 2:88,122,882...88,255,281
JBrowse link
G HTR1A 5-hydroxytryptamine receptor 1A ISO RGD PMID:21352823 RGD:5683628 NCBI chr16:42,479,812...42,484,365
Ensembl chr16:42,478,923...42,484,304
JBrowse link
G MAPT microtubule associated protein tau treatment ISO associated with Parkinsonian Disorders RGD PMID:25511986 RGD:13800920 NCBI chr12:17,098,259...17,211,483
Ensembl chr12:17,095,587...17,211,373
JBrowse link
G MTOR mechanistic target of rapamycin kinase treatment ISO associated with Parkinsonian Disorders RGD PMID:23938307 RGD:10040953 NCBI chr 6:71,286,989...71,412,913
Ensembl chr 6:71,286,989...71,412,888
JBrowse link
G PDYN prodynorphin treatment
severity
ISO CTD Direct Evidence: marker/mechanism
associated with Parkinsonism
associated with Parkinsonism;protein:increased expression:striatum
CTD
RGD
PMID:9767399 PMID:10869049 PMID:17884291 PMID:21737418 RGD:401850563 RGD:401851046 RGD:401900134 NCBI chr17:33,505,075...33,521,534
Ensembl chr17:33,505,079...33,521,532
JBrowse link
G PENK proenkephalin treatment
disease_progression
ISO mRNA:increased expression:brain:striatum:
associated with Parkinsonism
associated with Parkinsonism;mRNA:increased expression:striatum
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:9767399 PMID:10869049 PMID:20456008 PMID:26113400 RGD:10003039 RGD:401851054 RGD:401900134 NCBI chr 4:75,525,497...75,530,403
Ensembl chr 4:75,525,555...75,530,876
JBrowse link
G PPP1R1B protein phosphatase 1 regulatory inhibitor subunit 1B treatment ISO associated with Parkinsonian Disorders RGD PMID:27771532 RGD:13514053 NCBI chr12:22,681,244...22,690,978
Ensembl chr12:22,680,980...22,690,952
JBrowse link
G RASGRF1 Ras protein specific guanine nucleotide releasing factor 1 ISO CTD Direct Evidence: therapeutic CTD PMID:21115823 NCBI chr 7:48,121,415...48,246,749
Ensembl chr 7:48,121,419...48,246,749
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO protein:increased expression:nucleus, brain RGD PMID:18590723 RGD:2298778 NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
JBrowse link
G RGS4 regulator of G protein signaling 4 treatment ISO associated with Parkinsonian Disorders RGD PMID:24969021 RGD:13524515 NCBI chr 4:87,383,336...87,390,478
Ensembl chr 4:87,383,345...87,390,893
JBrowse link
G RGS9 regulator of G protein signaling 9 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:18160641 PMID:24663062 NCBI chr12:12,015,321...12,087,982
Ensembl chr12:12,015,321...12,087,976
JBrowse link
G TH tyrosine hydroxylase ISO CTD Direct Evidence: therapeutic CTD PMID:15659429 NCBI chr 2:1,499,628...1,506,180
Ensembl chr 2:1,499,620...1,506,170
JBrowse link
Drug-Induced Enteropathy term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NOS3 nitric oxide synthase 3 treatment ISO RGD PMID:29064425 RGD:13450913 NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
JBrowse link
drug-induced hepatitis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC2 ATP binding cassette subfamily C member 2 susceptibility
no_association
ISO DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human)
DNA:SNPs:multiple:
RGD PMID:17502832 PMID:22178260 RGD:14700816 RGD:14700817 NCBI chr14:110,955,698...111,038,898
Ensembl chr14:110,955,633...111,037,537
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 ISO DNA:hypermethylation:promoter RGD PMID:23619520 RGD:14700910 NCBI chr14:141,690,737...141,703,078
Ensembl chr14:141,690,426...141,736,817
JBrowse link
G HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase ISO RGD PMID:16140414 RGD:2316848 NCBI chr 2:84,380,245...84,401,117
Ensembl chr 2:84,380,224...84,402,957
JBrowse link
G LPAR1 lysophosphatidic acid receptor 1 ISO protein:increased expression:liver (mouse) RGD PMID:12201952 RGD:10054288 NCBI chr 1:251,811,583...251,979,828
Ensembl chr 1:251,811,584...251,979,159
JBrowse link
Efavirenz, Poor Metabolism of term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2B6B cytochrome P450 family 2 subfamily B member 6B ISO ClinVar Annotator: match by term: Efavirenz, poor metabolism of ClinVar
OMIM
PMID:15194512 PMID:15622315 PMID:15668854 PMID:15825040 PMID:15864119 More... NCBI chr 6:49,158,175...49,173,872
Ensembl chr 6:49,110,812...49,178,334
JBrowse link
erythema nodosum term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G C3 complement C3 ISO associated with Leprosy RGD PMID:2783924 RGD:7421527 NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
JBrowse link
G CFB complement factor B ISO associated with Leprosy RGD PMID:2783924 RGD:7421527 NCBI chr 7:24,034,077...24,040,523
Ensembl chr 7:24,033,740...24,041,179
JBrowse link
G LTA lymphotoxin alpha ISO associated with Sarcoidosis;DNA:polymorphism:intron RGD PMID:19225544 RGD:8548773 NCBI chr 7:23,696,387...23,698,280
Ensembl chr 7:23,696,040...23,698,299
JBrowse link
G TNF tumor necrosis factor susceptibility ISO associated with Inflammatory Bowel Diseases;DNA:polymorphisms: :-1031T>C(human) RGD PMID:12198697 RGD:7364926 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
JBrowse link
G VDR vitamin D receptor susceptibility ISO associated with Behcet Syndrome;DNA:polymorphism: : rs7975232(human) RGD PMID:24880677 RGD:13217417 NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,266,475
JBrowse link
Halothane Hepatitis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GPT glutamic--pyruvic transaminase treatment ISO RGD PMID:28921207 RGD:14975164 NCBI chr 4:297,747...302,498
Ensembl chr 4:297,748...320,056
JBrowse link
Hand-Foot Syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G KDR kinase insert domain receptor treatment ISO DNA:polymorphism:cds:p.H472Q(human) RGD PMID:20630084 RGD:8552374 NCBI chr 8:41,809,116...41,856,379
Ensembl chr 8:41,809,122...41,856,336
JBrowse link
Metabolic Side Effects of Drugs and Substances term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 ISO Associated with incense smoke exposure;mRNA:increased expression:heart (rat) RGD PMID:25687613 RGD:401900684 NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 treatment ISO associated with nitrate tolerance
Associated with incense smoke exposure;mRNA:increased expression:heart (rat)
associated with nitrate tolerance; protein:decreased expression:thoracic aorta (rat)
RGD PMID:12688525 PMID:16520233 PMID:25687613 RGD:401900296 RGD:401900656 RGD:401900684 NCBI chr 7:58,779,529...58,786,155
Ensembl chr 7:58,779,475...58,786,100
JBrowse link
G CYP2B6B cytochrome P450 family 2 subfamily B member 6B susceptibility ISO DNA:SNP: :CYP2B6*6 (516G>T,785A>G) ((human) RGD PMID:27289271 RGD:401901173 NCBI chr 6:49,158,175...49,173,872
Ensembl chr 6:49,110,812...49,178,334
JBrowse link
G NPPA natriuretic peptide A ISO Associated with incense smoke exposure;mRNA:increased expression:heart (rat) RGD PMID:25687613 RGD:401900684 NCBI chr 6:71,919,557...71,921,345
Ensembl chr 6:71,918,845...71,921,405
JBrowse link
G NPPB natriuretic peptide B ISO Associated with incense smoke exposure;mRNA:increased expression:heart (rat) RGD PMID:25687613 RGD:401900684 NCBI chr 6:71,930,374...71,931,843
Ensembl chr 6:71,930,382...71,932,254
JBrowse link
Nakajo Syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PSMB8 proteasome 20S subunit beta 8 ISO ClinVar Annotator: match by term: Nodular erythema digital changes ClinVar PMID:20159315 PMID:20534754 PMID:21129723 PMID:21953331 PMID:25741868 More... NCBI chr 7:25,058,456...25,061,666
Ensembl chr 7:25,058,465...25,062,245
JBrowse link
nephrotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CACNA1G calcium voltage-gated channel subunit alpha1 G treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr12:26,838,633...26,912,344
Ensembl chr12:26,844,079...26,912,110
JBrowse link
G CACNA1S calcium voltage-gated channel subunit alpha1 S treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr10:23,503,701...23,567,797
Ensembl chr10:23,502,898...23,568,058
JBrowse link
G CAMK2A calcium/calmodulin dependent protein kinase II alpha treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 2:151,248,356...151,353,907
Ensembl chr 2:151,248,358...151,308,706
JBrowse link
G CYP24A1 cytochrome P450 family 24 subfamily A member 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr17:55,110,546...55,130,328
Ensembl chr17:55,110,590...55,130,363
JBrowse link
G CYP27B1 cytochrome P450 family 27 subfamily B member 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 5:23,053,129...23,058,865
Ensembl chr 5:23,053,892...23,058,470
JBrowse link
G GATM glycine amidinotransferase ISO RGD PMID:15462098 PMID:19664912 RGD:329961309 RGD:329961312 NCBI chr 1:126,361,968...126,378,705
Ensembl chr 1:126,361,945...126,380,871
JBrowse link
G GC GC vitamin D binding protein treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
JBrowse link
G GPX3 glutathione peroxidase 3 treatment ISO RGD PMID:22115772 PMID:23662110 PMID:27412471 RGD:401827919 RGD:401827924 RGD:401827925 NCBI chr16:71,980,467...71,989,011
Ensembl chr16:71,980,475...71,989,026
JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr16:66,162,318...66,208,868 JBrowse link
G ITPR1 inositol 1,4,5-trisphosphate receptor type 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr13:61,068,131...61,398,918
Ensembl chr13:61,068,126...61,398,912
JBrowse link
G NOS2 nitric oxide synthase 2 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
JBrowse link
G RYR1 ryanodine receptor 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 6:47,339,759...47,458,457
Ensembl chr 6:47,343,768...47,458,458
JBrowse link
G S100A1 S100 calcium binding protein A1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 4:96,007,026...96,012,305
Ensembl chr 4:96,007,028...96,012,310
JBrowse link
G S100B S100 calcium binding protein B treatment ISO RGD PMID:37244046 RGD:329853759
G TGFB1 transforming growth factor beta 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
JBrowse link
G VDR vitamin D receptor treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,266,475
JBrowse link
neurotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G MBP myelin basic protein treatment ISO RGD PMID:33166664 RGD:213230154 NCBI chr 1:147,649,516...147,685,289
Ensembl chr 1:147,590,865...147,685,290
JBrowse link
G MOG myelin oligodendrocyte glycoprotein treatment ISO RGD PMID:33166664 RGD:213230154 NCBI chr 7:22,595,565...22,606,137
Ensembl chr 7:22,595,510...22,610,817
JBrowse link
G MYRF myelin regulatory factor treatment ISO RGD PMID:33166664 RGD:213230154 NCBI chr 2:9,761,230...9,795,873 JBrowse link
G PLP1 proteolipid protein 1 treatment ISO RGD PMID:33166664 RGD:213230154 NCBI chr  X:84,676,627...84,683,517
Ensembl chr  X:84,666,733...84,685,058
JBrowse link
NSAID-Enteropathy term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP9 caspase 9 ISO RGD PMID:25014874 RGD:13782349 NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
JBrowse link
G PTGER3 prostaglandin E receptor 3 treatment ISO RGD PMID:11991626 RGD:10003093 NCBI chr 6:141,958,955...142,160,437
Ensembl chr 6:141,958,955...142,161,286
JBrowse link
G PTGER4 prostaglandin E receptor 4 treatment ISO RGD PMID:11991626 RGD:10003093 NCBI chr16:25,670,832...25,686,556
Ensembl chr16:25,670,862...25,686,552
JBrowse link
Poor Metabolism of Thiopurines, 1 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G TPMT thiopurine S-methyltransferase ISO ClinVar Annotator: match by term: THIOPURINES, POOR METABOLISM OF, 1 OMIM
ClinVar
PMID:8561894 PMID:9931345 PMID:25741868 NCBI chr 7:13,821,656...13,846,107
Ensembl chr 7:13,820,866...13,846,012
JBrowse link
Poor Metabolism of Thiopurines, 2 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NUDT15 nudix hydrolase 15 ISO ClinVar Annotator: match by term: Thiopurines, poor metabolism of, 2 OMIM
ClinVar
PMID:22992668 PMID:25108385 PMID:25624441 PMID:25741868 PMID:26033531 More... NCBI chr11:19,572,963...19,584,565 <